Agency of the United States Department of Health and Human Services
POPULARITY
Categories
469 episodes with fda
421 episodes with fda
300 episodes with fda
401 episodes with fda
208 episodes with fda
256 episodes with fda
145 episodes with fda
195 episodes with fda
195 episodes with fda
131 episodes with fda
107 episodes with fda
73 episodes with fda
199 episodes with fda
55 episodes with fda
84 episodes with fda
85 episodes with fda
72 episodes with fda
75 episodes with fda
143 episodes with fda
94 episodes with fda
66 episodes with fda
68 episodes with fda
135 episodes with fda
150 episodes with fda
111 episodes with fda
247 episodes with fda
61 episodes with fda
77 episodes with fda
52 episodes with fda
37 episodes with fda
104 episodes with fda
47 episodes with fda
47 episodes with fda
121 episodes with fda
100 episodes with fda
97 episodes with fda
73 episodes with fda
95 episodes with fda
73 episodes with fda
71 episodes with fda
50 episodes with fda
66 episodes with fda
44 episodes with fda
45 episodes with fda
53 episodes with fda
50 episodes with fda
69 episodes with fda
67 episodes with fda
85 episodes with fda
66 episodes with fda
38 episodes with fda
57 episodes with fda
54 episodes with fda
99 episodes with fda
Alison Smart returns to share vital updates on the ongoing fight to save Levemir insulin. Discover recent FDA progress, bipartisan support, and why this insulin remains crucial for healthy pregnancies. Alison is a returning guest, 1652 Save Levemir. Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** Use code JUICEBOX to save 20% at Cozy Earth CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof. ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
It's Friday, March 13th, A.D. 2026. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com. I'm Adam McManus. (Adam@TheWorldview.com) By Adam McManus Why some Iranians dance during war Why are some Iranians dancing while war is unfolding in their country? For more than 47 years, the Islamic regime ruling Iran has governed through fear, oppression, and bloodshed, reports International Christian Concern. The hands of this regime are stained with the blood of thousands of Iranian and American citizens. It has been one of the world's leading sponsors of terrorism, spreading violence far beyond Iran's borders. At home, it has relentlessly persecuted Christians — executing some, imprisoning many, and forcing countless others into exile. Believers have been torn from their families, their homes, and their homeland, scattered across the world simply because they chose to follow Jesus Christ. When some Iranians celebrate or dance these days, it is not because they love war. It is because they have lived for decades under a darkness that few outside the country can fully comprehend. For many Iranians, these moments carry the fragile hope that the long night of oppression may finally be nearing its end. And freedom might be dawning once again. Congress hopes to Safeguard Women from Chemical Abortion On Wednesday, Republican Senator Josh Hawley of Missouri took to the podium in the Senate Judiciary hearing room to deliver a clear message: the abortion pill Mifepristone is not just risky — it's “inherently dangerous.” And it's up to Congress to regulate it, reports The Washington Stand. At a press conference, the Missouri senator unveiled his new legislation, the Safeguarding Women from Chemical Abortion Act. This bill seeks to strip Mifepristone — the drug responsible for the majority of U.S. abortions — of its longstanding approval from the Food and Drug Administration. According to recent data from the Guttmacher Institute, chemical abortions made up 63% of all abortions in 2023, with the trend only accelerating in the years since. Senator Hawley didn't hold back, blasting the FDA for letting mail-order shipments flood the country, wiping out state-level protections for the unborn and leaving women to face severe complications. HAWLEY: “In 11% of cases, women who take the drug, Mifepristone for use in an abortion experience a serious adverse health event. Now, that's the technical term. What it means, in practice, is internal infections, sepsis, hemorrhaging, a trip to the emergency room, a life-threatening condition. In 11% of cases!” Hawley added, “It is time for Congress to do something about this racket, And it is a racket. It is time for Congress to ban the use of Mifepristone for abortion, and it is time for Congress to give the victims — the survivors — … the right to recover.” He framed the fight as a double victory: shielding vulnerable women from what many see as a profit-driven chemical experiment and protecting unborn life when the courts and agencies will not. Call your Congressman today and urge him or her to vote for The Safeguarding Women from Chemical Abortion Act. The number is 202-224-3121. That's 202-224-3121. You can call and get a live operator 24 hours a day, 7 days a week and simply leave a message. The manufacturers and distributors of this heinous Abortion Kill Pill are well described in Isaiah 59:7. “Their feet rush into sin; they are swift to shed innocent blood. They pursue evil schemes; acts of violence mark their ways.” Armed man rammed truck into Michigan synagogue On Thursday, authorities say a man, armed with a rifle, rammed his truck into Temple Israel in West Bloomfield, Michigan, before the vehicle caught fire, prompting an active shooter response, reports NewsNation. Oakland County Sheriff Michael Bouchard said the synagogue's security team engaged the suspect with gunfire after he breached the building and drove down a hallway. The suspect was later found dead. His body was badly burned. BOUCHARD: “No kids, this is the important thing, no kids or no staff was injured whatsoever. One of the lead security people was hit by the car and was taken to the hospital for treatment. That individual should be okay.” The sheriff said the suspect appears to have been the only person in the vehicle. CNN host makes humiliating on-air correction after getting NYC terror attack story wrong During a “Stop the Islamic Takeover of New York City” rally on Saturday, two men were arrested for throwing improvised explosive devices at anti-Islam protesters. Authorities later discovered these men were inspired by the Islamic State terrorist group. The incident took place outside Gracie Mansion, the official residence of New York Democratic Mayor Zohran Mamdani. However, CNN's Abby Phillip, host of “NewsNight,” claimed on Tuesday that the men were not targeting the crowd, but the mayor, a Muslim himself, reports The Western Journal. PHILLIP: “Two Republicans say Muslims don't belong here after an attempted terror attack on New York Mayor Zohran Mamdami.” Samuel Short wrote, “The intent was obvious as CNN and Phillip would love to blame anyone who criticizes Islam as a violent terrorist. Oh, the irony.” On Wednesday morning, Phillip published a correction on the social media platform X. She also issued a correction on air Wednesday night. PHILIP: “This morning I issued a correction first thing in the morning, on X, for a mistake that I made in last night's show. But I also wanted to do so on air as well. “I incorrectly said that the bombs that were thrown by ISIS-inspired suspects in New York over the weekend were directed at Mayor Mamdani. They were not. I failed to catch and correct that mistake in real time, and I take full responsibility for that.” Former Southern Baptist Convention President entered hospice Former Southern Baptist Convention President Steve Gaines, age 68, has entered hospice care, over two years after he was diagnosed with kidney cancer, reports The Christian Post. Bellevue Baptist Church Pastor Ben Mandrell, who replaced Gaines as lead pastor of the Cordova, Tennessee-based megachurch last year, wrote a letter to the congregation earlier this week explaining the situation. He wrote, “Steve has faithfully served the Lord and shepherded so many people through the years. He's been a great pastor, mentor and friend. Let's honor him and his family by lifting them up before the Lord.” Butler Bill, which prohibited teaching evolution, signed into law And finally, on this day, March 13, 1925, Tennessee Governor Austin Peay signed the "Butler Bill” which prohibited the teaching of the false theory of macro evolution in public schools. The law was introduced by Tennessee House of Representatives member John Washington Butler, for whom the law was named. The law was challenged and upheld later that year in a famous trial in Dayton, Tennessee called the Scopes Trial which involved a raucous confrontation between prosecution attorney and Christian leader, William Jennings Bryan, and prominent defense attorney and religious agnostic, Clarence Darrow. On parental rights, Bryan said, “The parents have a right to say that no teacher, paid by their money, shall rob their children of faith in God.” On the nature of evolution, Bryan said, "The first objection to Darwinism is that it is only a guess and was never anything more. It is millions of guesses strung together.” And, on his Christian worldview, Bryan said, "I would rather begin with God and reason down than begin with a piece of dirt and reason up.” Sadly, William Jennings Bryan died five days after the Scopes Trial concluded. The Butler Law was not repealed until 1967. Genesis 1:1 declares, “In the beginning, God created the heavens and the Earth.” Close And that's The Worldview on this Friday, March 13th, in the year of our Lord 2026. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com. Plus, you can get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.
Erin Ryan and MS NOW's Brandy Zadrozny break down the newly available FBI interviews with a woman who accused Trump of sexual assault that the DOJ tried to bury, a bizarre attempt at image rehab for Peggy Siegal aka “The Grande Dame of the Epstein Files,” and the Iranian women's soccer team's quest for asylum. They also discuss and review Candace Owens' latest series, The Bride of Charlie. And of course, we wrap up with Sani-Petty.For a closed-captioned version of this episode, click here. For a transcript of this episode, please email transcripts@crooked.com and include the name of the podcast.DOJ releases Epstein files with accusations against Trump (The Miami Herald 3/6)Fuzzy memories and hard facts: An SC accuser's claims against Epstein, Trump examined (The Post and Courier 3/8)The Grande Dame of the Epstein Files (NY Mag 3/4)Five Iranian footballers granted Australian visas after anthem protest (BBC 3/10)Estrogen patches harder to find as FDA pushes hormone therapy (The Hill 3/5)The Widow and the Firebrand: How Candace Owens Turned a Conservative Succession Into a Crusade Against Erika Kirk (Hollywood Reporter 3/5)
Testosterone levels in 40-year-old men are 30 percent lower than their fathers, and most doctors still have no idea what to do about it. -Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR Host Dave Asprey sits down with Dr. Justin Houman, a nationally recognized urologist and Assistant Professor of Urology at Cedars-Sinai Medical Center. Fellowship-trained and specializing in men's health, male fertility, and sexual medicine, Dr. Houman combines cutting-edge medical advancements with holistic lifestyle strategies to help men optimize testosterone, sexual health, and reproductive performance at every age. Together, Dave and Dr. Houman tear through the myths, the bad science, and the outdated medical dogma around testosterone, erectile function, fertility, and male sexual health. They cover everything from why testosterone levels have collapsed in a single generation, to the real story behind the FDA black box warning, to practical protocols for men who want to optimize without sacrificing fertility. This is the masterclass on men's health that no one else is having on record. This is essential listening for anyone serious about biohacking, longevity, human performance, hormone optimization, brain optimization, anti-aging, functional medicine, mitochondria, and Smarter Not Harder approaches to male health. You'll Learn: Why testosterone levels in 40-year-old men are 30 percent lower than their fathers and what is driving the collapse How low testosterone connects to anxiety, depression, high cholesterol, blood sugar dysregulation, and all-cause mortality risk The truth about the original testosterone and heart attack study and why it still has not been retracted How to preserve fertility while on TRT using Clomid, enclomiphene, and HCG Why daily low-dose Cialis is one of the cheapest and most effective longevity drugs available What shockwave therapy, PRP, exosomes, and Botox injections actually do for erectile function How red light therapy at 660 and 850 nanometers supports testosterone production and nocturnal erections The supplement stack including ashwagandha, tongkat ali, fadogia agrestis, and creatine that supports healthy hormone levels Why porn-induced ED is epidemic in young men and how to reverse it How PT-141 and peptides fit into a complete male optimization protocol Thank you to our sponsors! Pre-order Arthur Brook's new book today at themeaningofyourlife.com. You can also see Arthur speak live at the 2026 Beyond Biohacking Conference fatty15 | Go to https://fatty15.com/dave and save an extra $15 when you subscribe with code DAVE.Establish a powerful foundation for sustained wellness with Pique. Unlock 20% off: piquelife.com/DAVE BrainTap | Go to http://braintap.com/dave to get $100 off the BrainTap Power Bundle. Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights in health, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: testosterone, low testosterone, TRT, testosterone replacement therapy, male fertility, erectile dysfunction, ED, men's health, sexual health, hormone optimization, Dave Asprey, biohacking, longevity, anti-aging, human performance, Dr. Justin Houman, Cedars-Sinai, urologist, shockwave therapy, PRP, exosomes, Botox penis, red light therapy, nitric oxide, Cialis, tadalafil, Viagra, sildenafil, PT-141, Melanotan, peptides, ashwagandha, tongkat ali, fadogia agrestis, creatine, Danger Coffee, Smarter Not Harder, Kyzatrex, clomid, enclomiphene, HCG, prolactin, cabergoline, porn-induced ED, refractory period, fertility, sperm health, spermatogenesis, FSH, LH, estrogen, aromatization, functional medicine, supplements, mitochondria, circadian rhythm, sleep optimization, cortisol, microplastics, inflammation, cardiovascular health, dementia, all-cause mortality, nocturnal erections, penile health, male optimization Resources: • Learn More About Dr. Houman's Work At: https://houmanmd.com/ • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 00:00 – Introduction 01:15 – Low Testosterone Epidemic 04:23 – Ejaculation & Testosterone 07:30 – Refractory Period & Aging 09:58 – Porn-Induced ED 11:09 – Cabergoline & Prolactin Management 12:42 – Oral Testosterone 13:24 – Testosterone Target Levels 16:46 – Supplements for Testosterone 18:46 – Anxiety-Based ED 26:23 – Penis Enhancement Options 27:37 – Shockwave Therapy 28:57 – Cialis for Longevity 29:56 – Fat & Filler Injections 34:50 – Pre-Sex Optimization 40:13 – Red Light Therapy 42:18 – Heat & Cold for Testosterone 43:35 – Underwear & Microplastics 44:58 – Testosterone & Fertility 49:15 – HCG & Preserving Fertility 52:00 – Testosterone Dosing Timing 53:22 – Creatine & Mitochondrial Health 55:20 – Overtraining Effects 56:24 – Peptides (PT-141) 59:08 – Optimal Diet for Fertility See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Ready to turn your personal passion into a thriving business? Join me as I sit down with Shelly Garg, founder of Wave Kids, a revolutionary kids' lifestyle beverage brand. We dive into her mission to disrupt the kids' beverage market with healthier, fun options that kids actually want to drink. Shelly shares her unique insights as both a mom and an FDA attorney, offering valuable advice for aspiring mompreneurs. Tune in to discover how you can empower your children to make smarter choices, all while enjoying their favorite beverages. Plus, get insider tips on building a business that makes a difference! Check out www.wave-kids.com and use Mompreneur10 for 10% off your order! Instagram: https://www.instagram.com/hellowavekids/ Facebook: Wave Kids
In this episode of Denatured, you'll listen to Oxana Iliach, senior director of regulatory strategy at Certara and Vera Pomerantseva, director of product management for risk-based quality management at eClinical Solutions. We speak about how the FDA's latest decision to have one, rather than two pivotal studies, for new drug applications raises the bar for data collection and risk-based management.HostJennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsOxana Iliach, Senior Director of Regulatory Strategy, CertaraVera Pomerantseva, Director of Product Management for RBQM, eClinical SolutionsDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.
Tim Blake Nelson got a rocket on him! For simple, online access to personalized and affordable care for Hair Loss, ED, Weight Loss, and more, visit https://Hims.com/SUPERMEGA Featured products include compounded drug products, which the FDA does not approve or verify for safety, effectiveness, or quality. Prescription required. See website for full details, restrictions, and important safety information. Individual results may vary. Based on studies of topical and oral minoxidil and finasteride. Head to https://factormeals.com/supermega50off and use code supermega50off to get 50% and free breakfast for a year! *Offer only valid for new Factor customers with code and qualifying auto-renewing subscription purchase. Sign up for your $1 per month trial today at https://Shopify.com/super Follow Matt: @matthwatson Follow Ryan: @elirymagee Follow the show: @supermegashow Learn more about your ad choices. Visit podcastchoices.com/adchoices
A new week means new questions! Hope you have fun with these!What is the name of "The Princess Bride" in "The Princess Bride"?Which is the second largest of the Channel Islands?What unit is used to measure the flow of electric current in a circuit?In South Park, Cartman tricks Butters into going missing to get an invitation to Kyle's birthday party at what real-life Mexican-themed restaurant the South Park creators now own?Mike Tyson vs Evander Holyfield, a professional boxing match that happened in June of 1997, shares its name with which William Faulkner novel?How many windows are in the crown of the Statue of Liberty?The Nokia 6110 included which game on it?"The Paris Apartment" and "The Guest List" are both novels by which author who has been tapped to write "Murder at the Grand Alpine Hotel" the first new Miss Marple novel in 50 years?In Greek Mythology, who had a lesser-known twin brother name Iphicles who was his loyal companion on adventures including the Calydonian Boar Hunt?If Matthew Perry needed handmade candles for his Phillip Marlowe-themed murder mystery party, what type of craftsman would he call?Vivienne Westwood is credited with bringing what kind of fashion into the mainstream, which she described as " a way of "seeing if one could put a spoke in the system"?Which planet is the coldest in the solar system?Out of the 36 spices recognized by the FDA, which are alphabetically first and last?The fastest-moving muscle in the human body is located where?Which actor is facing backlash after saying "I don't want to be working in ballet or opera, or, you know, things where it's like "Hey, keep this thing alive, even though no one cares about this anymore"MusicHot Swing, Fast Talkin, Bass Walker, Dances and Dames, Ambush by Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 3.0 http://creativecommons.org/licenses/by/3.0/Don't forget to follow us on social media:Patreon – patreon.com/quizbang – Please consider supporting us on Patreon. Check out our fun extras for patrons and help us keep this podcast going. We appreciate any level of support!Website – quizbangpod.com Check out our website, it will have all the links for social media that you need and while you're there, why not go to the contact us page and submit a question!Facebook – @quizbangpodcast – we post episode links and silly lego pictures to go with our trivia questions. Enjoy the silly picture and give your best guess, we will respond to your answer the next day to give everyone a chance to guess.Instagram – Quiz Quiz Bang Bang (quizquizbangbang), we post silly lego pictures to go with our trivia questions. Enjoy the silly picture and give your best guess, we will respond to your answer the next day to give everyone a chance to guess.Twitter – @quizbangpod We want to start a fun community for our fellow trivia lovers. If you hear/think of a fun or challenging trivia question, post it to our twitter feed and we will repost it so everyone can take a stab it. Come for the trivia – stay for the trivia.Ko-Fi – ko-fi.com/quizbangpod – Keep that sweet caffeine running through our body with a Ko-Fi, power us through a late night of fact checking and editing!Quiz, trivia, games, pub+trivia, pub+quiz, competition, education, comedy
In this episode of More Than A Pretty Face, Dr. Azi sits down with board-certified dermatologist, Dr. Arisa Ortiz, to break down the science behind skin tightening and today's most popular non-invasive treatments. They discuss how collagen changes with age, how ultrasound technology like Softwave works, and how it compares to other options like Ultherapy and RF microneedling. The conversation also covers combination treatments, common patient concerns about fat loss and filler, and how dermatologists approach natural-looking rejuvenation without surgery. Dr. Arisa also shares insights on her AI platform designed to help educate patients before their appointments, plus a rapid-fire round of skincare favorites. Timeline of what was discussed: 00:00 - Intro + Meet Dr. Arisa Ortiz 01:02 - Why Skin Tightening Is So Popular 01:54 - What Skin Tightening Actually Means 04:00 - Softwave vs Ultherapy 05:03 - How Ultrasound Targets Collagen 08:01 - Areas You Can Treat With Softwave 08:42 - AziMD Skincare Break 09:49 - Combining Softwave + Radiesse 11:30 - When You'll See Results 12:13 - Science Behind Softwave 15:43 - Best Age to Start Skin Tightening 18:21 - Threads: Pros & Risks 21:49 - FDA Warning on RF Microneedling 24:00 - Favorite Treatments Dr. Arisa Does 25:33 - AI Platform: Your Pre-Visit 29:27 - Rapid Fire Skincare Questions 30:38 - Final Thoughts + Outro ______________________________________________________________ Follow Dr. Arisa Ortiz on Instagram: @arisaortizmd Dr. Arisa Ortiz is a board-certified dermatologist and the Director of Laser and Cosmetic Dermatology at UC San Diego. She specializes in laser treatments, skin rejuvenation, and non-invasive cosmetic procedures. A nationally and internationally recognized expert, Dr. Ortiz has published numerous peer-reviewed articles and lectures on advanced dermatologic and aesthetic technologies. Known for her research-driven approach, she focuses on safe, effective treatments that deliver natural-looking results. Follow Sofwave on Instagram: @sofwavemed SofwaveTM is an FDA-cleared, non-invasive ultrasound treatment designed to improve skin laxity and reduce fine lines and wrinkles. Using advanced ultrasound technology, Sofwave delivers controlled heat to the mid-dermis to stimulate collagen and elastin production—helping to tighten and lift the skin over time. The treatment is safe for all skin types, requires little to no downtime, and is commonly used on the face, neck, and other areas where skin firmness and texture need improvement. ______________________________________________________________ Submit your questions for the podcast to Dr. Azi on Instagram @morethanaprettyfacepodcast, @skinbydrazi, @nurselacie, on YouTube, and TikTok @skinbydrazi. Email morethanaprettyfacepodcast@gmail.com. Shop skincare at https://azimdskincare.com and learn more about the practice at https://www.lajollalaserderm.com/ The content of this podcast is for entertainment, educational, and informational purposes and does not constitute formal medical advice. © Azadeh Shirazi, MD FAAD.
Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References: https://pubmed.ncbi.nlm.nih.gov/41626799/https://www.ncbi.nlm.nih.gov/books/NBK548187/https://pubmed.ncbi.nlm.nih.gov/41626799/
These days, many internet influencers are promoting a wellness trend that sounds like something you might remember from high school bio: peptides. They’re being sold as ways to improve skin, reverse aging – basically, peptides have become THE answer to your choice of wellness issues. But most of what’s hawked on Instagram or TikTok is not approved by the FDA. . That could change: Health Secretary Robert F. Kennedy Jr. recently said on Joe Rogan’s podcast that he wants to relax restrictions on many peptides. In the meantime, people are accessing them through methods that some experts say are…. dangerous. Guests: Alex Hogan, a senior multimedia producer at STAT News and the host of STATus Report Related links: Inside the world of internet peptides | STAT News Peptides Are the New Wellness Cure-All | Intelligencer Why 'Anti-Aging' Peptide Shots Are Trending on Social Media | TIME Peptides take off as a DIY treatment but is that a good idea? : NPR Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.
After Friday's news that Center for Biologics Evaluation & Research Chief Vinay Prasad will leave the FDA—again—at the end of April, stocks for several rare disease drug developers popped. UniQure, in particular, was up 51% in premarket trading on Monday. Prasad in a meeting last Thursday with select journalists called the biotech's Huntington's treatment AMT-130 a “failed” therapy, according to STAT News. Shares of Replimune and REGENXBIO—which have suffered rejections during the past year—also rose.One person who is not impressed with the plethora of rare disease drug rejections of late—H.C. Wainwright said in a note Tuesday that there have been at least five cell and gene therapies they believe could have been approved under prior FDA officials—is Wisconsin Senator Ron Johnson. Tuesday, Bloomberg News reported that Johnson has launched an investigation into these recent denials.Johnson called the FDA's request that uniQure conduct a sham surgery-controlled trial of AMT-130 “bureaucratic idiocy,” according to the publication. Meanwhile, uniQure and the FDA appear to be on different pages regarding the design of this prospective trial, with uniQure Chief Medical Officer Walid Abi-Saab referring to a 10-12 hour surgery during which [burr] holes would be drilled in patients' skulls and Prasad claiming on a media call last week that it would require only “one to three nicks in the scalp.”In other news, no episode of The Weekly would be complete without our weekly weight loss segment. Roche and Zealand Pharma's amylin analog fell short of Eli Lilly's rival candidate eloralintide; AbbVie reported what analysts called “competitive” results, with its amylin analog eliciting nearly 10% weight loss at 13 weeks in a Phase 1 trial; and Regeneron touted a much-needed Phase 3 win for Hansoh-partnered dual GLP-1/GIPR agonist olatorepatide in China. Beyond data, Novo Nordisk and Hims & Hers are together again, with Novo striking a deal to sell its injectable and oral GLP-1 medicines through the telehealth provider.Elsewhere on the business side of biopharma, experts are reporting a cut-throat atmosphere behind doors on the M&A front as the supply of companies available to buy dwindles.
It's In the News, a look at the top headlines and stories in the diabetes community. This week's top stories: Stem Cell Islet Therapy Partnership, "Lyla's Law" Type 1 Testing Debate, Patient-Led Insulin Dosing for Gestational Diabetes, $3 Semaglutide Manufacturing, FDA GLP-1 Compounding Crackdown Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com transcript with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. I am definitely feeling better – that lingering cold is gone – but whew still recovering from non stop travel for the past five weeks. I have a great strech of time her at home, then going to Vegas for Brekathorugh T1D at the end of the month and we have two club 1921 events in April – Atlanta and Philly. Before we jump into the news – I need your community commercials! These have been a lot of fun, I announced them late last year – your voice on the show. All the instructions it's very easy in the show notes. Okay.. our top story this week: XX A biotech company developing stem-cell treatments for type 1 diabetes has announced a new research partnership aimed at improving the survival of transplanted insulin-producing cells. NewcelX, a clinical-stage company based in Switzerland, said it will work with Eledon Pharmaceuticals to study a combination approach. The goal is to help transplanted cells survive longer in the body by reducing the immune response that often leads to transplant rejection. If successful, the strategy could support longer-lasting islet cell replacement and move the therapy closer to becoming a functional treatment for people with type 1 diabetes. However, the companies have not yet released any safety or effectiveness data on the combination treatment, and financial details of the partnership were not disclosed. The research agreement is focused on exploring whether combining stem-cell-derived islets with targeted immune therapy can lead to longer-lasting cell transplants and improved outcomes for people with type 1 diabetes. https://www.stocktitan.net/news/ELDN/newcel-x-announces-strategic-collaboration-with-eledon-d10l1vqdofls.html XX Debate this week in the UK on whether testing for type 1 diabetes should become mandatory when children present with symptoms. The Westminster Hall debate, scheduled for 9 March, will consider calls for routine testing of babies, toddlers and young children who show signs associated with the condition. It follows a petition backing the move, dubbed 'Lyla's Law', which passed 121,000 signatures in December 2025. The campaign was launched by John Story after his two-year-old daughter, Lyla, died from diabetic ketoacidosis (DKA) on 3 May 2025, 16 hours after being diagnosed with tonsillitis. https://www.nursinginpractice.com/clinical/diabetes-and-endocrinology/diabetes-community-urged-to-call-on-mps-to-attend-lylas-law-debate/ XX A new study suggests that people with gestational diabetes who adjust their own insulin doses may reach healthy blood sugar levels faster than those whose doses are adjusted by clinicians. Half of the participants were assigned to adjust their own insulin doses using a simple rule: increase the dose by two units if fasting blood glucose was above 95 mg/dL, decrease it by two units if it dropped below 70 mg/dL, and keep the same dose if levels fell in between. The other half had their insulin adjusted by clinicians through weekly reviews. By the end of pregnancy, both groups had similar average fasting glucose levels before delivery: about 89 mg/dL in the patient-led group and 90 mg/dL in the clinician-led group. However, those adjusting their own insulin reached their blood sugar targets more quickly, averaging 1.8 weeks compared with 2.5 weeks for those managed by clinicians. The study also found lower risks of certain complications among the patient-led group. https://www.medscape.com/viewarticle/self-insulin-dosing-leads-control-gestational-diabetes-2026a1000729 XX A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent later this month, researchers said Friday, providing a major opportunity to boost health in low and middle-income countries. Semaglutide, the active molecule in Novo Nordisk's Ozempic and Wegovy will lose patent protection in countries such as Brazil, China, and India later this month, and researchers identified 150 countries where it was never patented. These researchers estimated it will cost as little as $3 to produce a month's supply of semaglutide, which in its branded form sells for around $200 a month in the United States. Another of the study's authors, Professor Francois Venter at the University of Witwatersrand in South Africa, said drugs to treat HIV, TB, malaria, and hepatitis are now available at prices close to production costs but still sufficient for generic manufacturers to operate. https://www.sciencealert.com/weight-loss-drugs-could-cost-just-3-a-month-to-make-as-patents-end XX Here in the US the FDA is stepping up its efforts to combat widespread GLP-1 drug compounding. In its latest offensive, the agency has unleashed a fresh set of 30 warning letters targeting telehealth companies it says make "false or misleading" claims about compounded versions of popular obesity drugs. The FDA says Compounded drugs can be important for overcoming shortages or meeting unique patient needs—but compounders should not try to compound drugs in a way that circumvents FDA's approval process." https://www.fiercepharma.com/pharma/fda-ramps-crackdown-glp-1-drug-compounders-fresh-batch-30-warning-letters XX Check your infusion sets for an issue: Unomedical, a subsidiary of Convatec and a supplier of insulin infusion sets to diabetes tech firms, has received a warning letter from the FDA. Inspectors raised concerns with leaking infusion sets, following a regulatory assessment of Unomedical's facility in Reynosa, Mexico, last summer. Unomedical supplies infusion sets to insulin pump makers including Medtronic, Tandem Diabetes Care and Beta Bionics. In a Feb. 3 statement, Convatec said the letter focuses on reporting procedures and quality protocols and does not place restrictions on producing, marketing or distributing any of Unomedical's products. Unomedical told the FDA in its responses that it plans to conduct a retrospective review of complaints involving serious injury or death by January and conduct additional training on complaint handling by May. https://www.medtechdive.com/news/fda-warns-insulin-infusion-set-maker-unomedical-over-leaks-mishandled-comp/813503/ XX Nearly four in ten people with type 2 diabetes do not take their medications as prescribed, according to a new research review published in Diabetologia in November 2025. Researchers examined existing studies on medication adherence, including how often patients miss doses, why it happens, and what strategies may help. They estimated that about 38% of patients with type 2 diabetes are not fully adherent to their medications. Adherence rates vary depending on the type of medication. About 63% to 68% of patients take oral glucose-lowering drugs as directed, while adherence drops to 43% to 54% for injectable GLP-1 medications and 41% to 64% for insulin. Poor adherence can lead to serious consequences. One retrospective study cited in the review found that patients who consistently took their glucose-lowering medications had a 31% lower risk of hospitalization or emergency department visits. The review also highlighted ways to improve adherence. Simplifying medication routines can help, such as using fixed-dose combination pills, which combine multiple drugs into a single tablet. Studies show these combinations are linked to better adherence and improved blood sugar control. Pharmacists can also play an important role by providing education, reviewing medications, setting up reminders, and helping patients organize their treatment plans. The researchers noted that support should be tailored to each patient. Older adults may benefit from simpler systems and caregiver support, while younger patients may respond better to digital tools like app-based reminders. The authors also found that measuring adherence is challenging and recommend using multiple methods, such as pharmacy records, patient interviews, and objective tests when possible. Overall, the review concludes that personalized, multi-step approaches lasting at least three months are most effective in helping people with type 2 diabetes stay on track with their medications. https://www.pharmacytimes.com/view/type-2-diabetes-medication-adherence-rates-remain-low-and-pharmacists-can-help XX New clinical trial shows metformin does not directly reverse insulin resistance in people with type 1 diabetes. Instead, it lowers the total amount of insulin required to keep blood glucose levels within the recommended range. The findings, published in Nature Communications, challenge long-held assumptions about how metformin works in type 1 diabetes. The results may help physicians refine treatment strategies and reduce the daily demands placed on people who rely solely on insulin therapy. "Insulin resistance is a growing problem in type 1 diabetes. Not only does it make regulating blood sugar levels difficult, but it is an underappreciated risk factor for heart disease, which is one of the biggest causes of health complications and deaths in those with type 1 diabetes," says Dr. Jennifer Snaith, endocrinologist and co-lead of the study. https://scitechdaily.com/groundbreaking-trial-reveals-unexpected-benefit-of-metformin-in-type-1-diabetes/ Tech news ahead, including updates from Sensonics, Dexcom & Tandem.. right after this…. Back ot the wnews.. XX Sensonics shares that it's secured FDA investigational device exemption (IDE) for its self-powered, battery-enabled Gemini sensor. It enrolled the first patients in the IDE trial and expects to complete that in the second half of 2026. Gemini builds on the implanted CGM to put the transmitter under the skin as well as the sensor. https://www.drugdeliverybusiness.com/senseonics-q4-2025-ide-gemini-cgm/ XX Medtronic Diabetes is now officially MiniMid, a stand alone public company. Medtronic acquired MiniMed 25 years ago announed last May that it would spin its diabetes business off. In their statement the company points out that MiniMed is the only diabetes tech company to sell both insulin pumps and continuous glucose monitors. https://www.investing.com/news/stock-market-news/medtronics-diabetes-unit-minimed-valued-at-53-billion-as-shares-fall-in-nasdaq-debut-4547518 XX Kevin Sayer heads back to Dexcom.. The former CEO is back in his position as executive chair of the Board, he'd stepped away for a medical leave. Dexcom (Nasdaq:DXCM) announced today in an SEC filing that former CEO Kevin Sayer has returned from his leave of absence. Sayer's return to the board comes just days after Dexcom announced a new board member. Last week, the company announced that it added Google SVP, Platforms and Devices, Rick Osterloh, to its board as well. https://www.drugdeliverybusiness.com/kevin-sayer-returns-dexcom-board-chair/ SAN DIEGO - DexCom, Inc. (NASDAQ:DXCM) announced the appointment of Rick Osterloh to its Board of Directors, effective today, according to a press release statement. Osterloh serves as Senior Vice President, Platforms & Devices at Google, where he oversees Android, Google Play, Chrome, and Google's hardware portfolio including Pixel phones, Google Nest devices, and Fitbit wearables. He has held this position since 2016. https://www.investing.com/news/company-news/dexcom-appoints-google-executive-rick-osterloh-to-board-93CH-4529662 XX Sequel Med Tech announced broad national availability of its twiist™ Automated Insulin Delivery (AID) System powered by Tidepool. After U.S. FDA clearance in 2024 and a controlled launch to optimize the twiist experience, the system is now fully available nationwide. The release says: Built on Sequel's proprietary iiSure™ Technology, the system enables earlier detection of delivery issues, alerting users to blockages up to nine times faster than other AID systems1, potentially reducing the risk of unexplained high glucose and giving you time to take action before experiencing severe high blood sugar or DKA2. Designed to expand access to automated insulin delivery, twiist is available through pharmacy channels with a flexible access model, XX Tandem Diabetes Care's Mobi automated insulin delivery system is now available with Android devices. In November, Tandem announced that it received FDA approval for the Android version of its Mobi mobile app. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software. At the time of the clearance, it said it would commence a limited rollout before the full launch — now underway — this year. Tandem launched Mobi in the U.S. in February 2024. It initially received FDA clearance for people with diabetes ages six and up in July 2023. The system then received expanded clearance for pediatric indications in April 2024, then later won CE mark in May 2025. Mobi features a 200-unit insulin cartridge and an on-pump button to provide an alternative to phone control for insulin boluses. It comes in at less than half the size of the flagship Tandem pump system, the t:slim X2 pump. Mobi can fit in a coin pocket, clip to clothing or go on the body with an adhesive sleeve. https://www.drugdeliverybusiness.com/tandem-diabetes-care-launches-mobi-android/
March 10, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Novo Nordisk drops patent case against Hims & Hers as companies reach agreement for Hims to offer FDA-approved Ozempic and Wegovy at standard pricing Whoop introduces hormone biomarker testing for 11 hormonal markers combined with wearable data and AI-driven insights as women become fastest-growing user segment Fitt Insider releases Scouting Report highlighting 50 early-stage startups shaping wellness across mental, physical, social, environmental, and existential health Today's episode is brought to you by AIIR — a modern communications and experiential agency for health, wellness, fitness, and performance brands. From earned media to events and creator-led campaigns, AIIR helps companies sharpen their story, earn attention, and build trust that compounds. Visit aiir.agency to learn more. More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co
With over 100 million treatments delivered worldwide, LightStim has played a major role in helping people reduce inflammation, improve circulation, ease chronic pain, and restore vitality.Red light therapy isn't just a beauty trend, it's a science-backed modality designed to support the body's natural healing processes. In this episode, Melissa sits down with Steve Marchese, CEO of LightStim, to explore how red light therapy delivers pain relief, supports mood, and promotes cellular renewal.Steve shares the inside story of how their FDA-cleared devices came to market, the legal battles shaping the wellness industry, and the myths that continue to confuse consumers. Keep listening, and you'll hear a discount code for 10% off to use at lightstim.com.In this episode, we explore:• What red light therapy does at the cellular level• How LightStim's FDA-cleared LED Bed was developed• Why red light therapy supports pain relief, mood, and cellular renewal• Legal and regulatory challenges within the wellness industry• Common myths and misinformation about red light therapy• The role of ATP, nitric oxide, dopamine, and serotonin in healing• What to look for in a red light therapy device that actually works• Where red light therapy is headed in the next 5–10 yearsWHERE TO FIND STEVE MARCHESEWebsite: https://www.lightstim.comInstagram: https://www.instagram.com/lightstimFacebook: https://www.facebook.com/LightStimYouTube: https://www.youtube.com/user/LightStimWHERE TO FIND MELISSASMGI: http://www.somatichealingjourneys.comMYOK: http://www.mindyourownkarma.com#MindYourOwnKarma #SomaticMindfulGuidedImagery #SMGI #SomaticHealingJourneys #RedLightTherapy #LightStim #SteveMarchese #PainRelief #MoodBoosting #lighttherapy #CellularRenewal #HealingWithLight #AlternativeHealing #WellnessInnovation #SkinHealth #FDAcleared #InflammationRelief #LEDbed #LEDlighttherapy #AlternativeHealing #AlternativeHealth
Send a textHealthcare is colliding with technology faster than most people realize.In this episode of FUTUREPROOF., I sit down with analyst Rajiv Leventhal, who covers the intersection of healthcare, pharma, and tech, to unpack three forces reshaping the system at once: AI, GLP-1 weight loss drugs, and the mental health impact of digital life.We start with AI as a health tool. Nearly a quarter of ChatGPT's global weekly users now use it for health-related prompts. That's not a niche behavior. It's a mainstream one. The question isn't whether people will turn to AI for medical guidance. They already are.The real tension is trust and liability. General-purpose AI tools aren't bound by HIPAA in the same way healthcare providers are. Yet they're increasingly acting as digital concierges — answering late-night pediatric questions, explaining lab results, and helping people prepare for appointments in a system where access is strained.And that system is strained. Even in major cities, patients can wait months — sometimes a year — to see specialists. When access gaps widen, alternative tools step in. AI isn't replacing doctors. It's filling holes.We then turn to GLP-1 drugs and the weight-loss explosion. What began as diabetes treatment became a cultural and commercial wave driven by social media, FDA approvals, and aggressive advertising. But beneath the surface is a regulatory gray market of compounded versions, patent battles, and telehealth platforms monetizing demand.Finally, we tackle social media's impact on mental health. The evidence linking heavy use — especially among teens — to anxiety and depression is growing, even if causation remains complex. Is this a regulation problem? A parental problem? A public health issue? Or another example of technology moving faster than governance?This episode isn't about hype.It's about what happens when broken systems create openings — and tech companies move into the space.Because when trust erodes and access declines, people don't wait.They improvise.
The grocery store can feel overwhelming and that's not accidental. In Episode 162 of NHA Today, guest host Kylie Buckner, RN, sits down with registered dietitian Cassandra Sampson to break down how to read food labels, avoid marketing traps, and become an empowered consumer. From the "health halo" effect to hidden added sugars and labeling loopholes, this episode gives listeners practical, real-world tools they can use immediately in the grocery aisle. If you've ever wondered: Is "plant-based" automatically healthy? What does "0g trans fat" really mean? How do I know if a packaged food is minimally processed? This conversation is for you. In this episode, you'll learn: Why the front of the package is marketing and the back is truth The FDA labeling loophole around "0 grams" claims The 5:1 carbohydrate-to-fiber rule How fiber and protein work together in whole plant foods What "clothe the carb" means for blood sugar stability How marketing influences grocery store behavior NHA Today is the official podcast of the National Health Association, dedicated to evidence-based, healthful living. Links & Resources National Health Association (NHA): https://www.healthscience.org Cassandra Sampson, RD: Instagram: https://www.instagram.com/nutrition_nibbles_dietitian Website: https://cassandragolden.com Kylie Buckner: Green Glow Lifestyle Podcast
In this episode, Therese Markow and Dr. John Kisiel discuss early cancer detection using liquid biopsies. Dr. Kisiel explains that liquid biopsies detect cancer signals in blood and urine, including tumor cells, fragments, proteins, and DNA. He highlights the FDA's approval of a blood test for colon cancer and the development of multi-cancer early detection tests. Dr. Kisiel notes that false positive and false negative rates vary by test. He emphasizes the potential of liquid biopsies to complement, not replace, standard screening methods and the need for further validation and clinical trials. Key Takeaways: Liquid biopsies have been used in the oncology community to test if cancer is still present, may need additional or more aggressive treatment, or if the cancer has come back. Each test will have its own false positive and false negative rate, partially based on where manufacturers set the thresholds for that positive/negative result. Peripheral blood-based tests for colon cancer do not detect polyps, and it's the finding and removing of polyps that actually offers the greatest preventive benefit, so that somebody never gets cancer in the first place. "Another word of cautious optimism, I think that I, personally, and many other people active in the space really view these as an addition to standard of care cancer screening and not a replacement." — Dr. John Kisiel Connect with Dr. John Kisiel: Professional Bio: https://www.mayo.edu/research/faculty/kisiel-john-b-m-d/bio-00092659 Connect with Therese: Website: www.criticallyspeaking.net Bluesky: @CriticallySpeaking.bsky.social Instagram: @criticallyspeakingpodcast Email: theresemarkow@criticallyspeaking.net Audio production by Turnkey Podcast Productions. You're the expert. Your podcast will prove it.
Brain Talk | Being Patient for Alzheimer's & dementia patients & caregivers
Dr. Michael Fossel, MD, PhD is a physician-scientist and recognized expert in aging and telomere biology. He serves as chairman of the board of Telocyte, a biotech company developing telomerase therapy for Alzheimer's disease, with FDA-sponsored human trials planned to target the underlying disease process. Fossel has authored more than 100 scientific publications and has lectured internationally, including at the National Institutes of Health. His work explores how processes like cell senescence — when aging cells stop working properly and can contribute to chronic inflammation — may help drive age-related diseases, including Alzheimer's.In the interview with Being Patient Founder Deborah Kan, Fossel argues that aging is not simply wear and tear, but a breakdown in the body's ability to maintain and repair cells over time. He explains why lifestyle habits may help slow aging but are unlikely to reset it and outlines why his research is focused on whether telomerase therapy could restore cellular function in Alzheimer's. He acknowledges that the science is still in its early stages, with major questions remaining about how much damage can be reversed, which patients might benefit most, and how soon these ideas can be tested in people.----If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: / being_patient_ Instagram: / beingpatientvoices Facebook: / beingpatientalzheimers LinkedIn: / being-patient Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/
Rejuvenecimiento celular, longevidad y envejecimiento: la ciencia acaba de dar un paso que podría cambiar la historia de la medicina. Hay descubrimientos científicos que parecen sacados de una película, hasta que empiezan a ocurrir en la vida real Hablamos del primer ensayo clínico aprobado por la FDA para intentar rejuvenecer tejido humano, un avance que está despertando preguntas enormes sobre salud, envejecimiento y el futuro de la humanidad. El Dr. José Hernández Poveda, médico experto en longevidad y fundador de Age Reversal en Mallorca, comparte lo que la ciencia está descubriendo sobre la epigenética, el envejecimiento celular y los avances que podrían redefinir la medicina, la salud y la forma en que vivimos nuestros años. Y si hablamos de vivir más y mejor, también vale la pena preguntarnos cómo queremos vivir hoy. Si quieres aprender a generar más ingresos sin vivir estresado ni sacrificar tu paz mental, te invito a mi masterclass: Cómo generar más ingresos con menos estrés.
Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Bonefrog https://BonefrogCoffee.com/ToddGet the new limited release, The Sisterhood, created to honor the extraordinary women behind the heroes. Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeIf you can't practice tough love, you don't really love. Let's practice tough love and examine why Mike Pence, and establishment Republicans like this who I am calling “Trump 2.0”.Episode Links:Mike Pence loves him some war with Iran BREAKING: Senate Leader John Thune confirms HE'S FORCING A VOTE on the SAVE America Act, he will put Democrats ON THE RECORD opposing the 85-15 issue The Republican Party is protecting Ilhan Omar from accountability. Rep Nancy Mace “I tried to subpoena her immigration records, her brother husband's immigration records, and IT WAS REPUBLICANS that killed my motion” It's a Uniparty. One Big Club.URGENT: Big Pharma wins again; Dr. Vinay Prasad is out as the FDA's chief medical's officer. Not coincidentally, stocks of drug companies are soaring.TRUMP: “You gotta lighten up on this, they might have come into our country illegally but they're good people and they're cheap workers. They're working now on farms, in luncheonettes and hotels. We're just focused on getting the murderers out.” So much for mass deportations.Trump: We'll bring in any Iranian refugees that aid the U.S Military! Trump complained about the Afghan INVADERS and now is doing the same thing. This is how we got invaded with people from the Middle East.HOMELAND: Trump's new pick for Secretary of Homeland recently voted to ALLOW "Refugee" Welfare Programs to continue to be funded at Biden-era levels. Mullin also comforted & HUGGED the cop who shot Ashli Babbitt: "He was distraught. I gave him a hug & said 'you did what you had to do.'" He also claimed Republican Senators were too "emotional" over Jan 6 to confirm Trump's pick Ed Martin for DC Prosecutor.Rep. Brian Mast: “Let's talk about Rep. Mace's resolution. Victims deserve protection. Witnesses deserve confidentiality. I voted to ensure survivors aren't forced to deal with the fallout of the public release of their sensitive information. I voted to send the resolution to the Ethics Committee so that it can be amended to adequately protect those who've done the brave thing and come forward.”Rep Anna Paulina Luna comes out and says it. She says the American People hate Congress for how corrupt they are. After both parties blocked disclosing slush funds using tax dollars to pay off their sexual assault charges, she loses it. “That's why the American people hate us”
In this episode, Etienne Nichols sits down with Staci Miller, a Human Factors and UX Strategist at GenUX, to demystify the role of human factors (HF) in the medical device regulatory pathway. Staci explains that many companies mistakenly treat HF as a "box-checking" exercise late in development, leading to costly submission delays or rejections when the FDA finds the documentation fails to tell a cohesive safety story.The conversation dives deep into the technical distinctions between a Use-Related Risk Analysis (URRA) and a User Failure Mode and Effects Analysis (uFMEA). Staci provides a framework for deciding which approach fits your product, emphasizing that while large conglomerates with post-market data may lean toward uFMEAs, startups and those with novel devices should prioritize the URRA to effectively map out user interactions without the crutch of existing market data.Finally, Staci addresses one of the most persistent myths in the industry: the idea that clinical trial data can replace human factors validation. She clarifies that while the two can overlap in specific, premeditated circumstances (such as complex implants like aortic valves), they serve entirely different masters—one focused on clinical efficacy and the other on the safety of the user interface across diverse environments.Key Timestamps04:12 – The common disconnect: Integrating Human Factors into ISO 14971 risk management.06:45 – URRA vs. uFMEA: How to choose based on your post-market data and predicate device status.10:30 – The "Definition of Done": Tracking the lifecycle of HF documentation from phase zero to market release.13:15 – System errors vs. Use errors: How to identify root causes during summative studies.18:50 – The "Clinical Trial Myth": Why efficacy data is not the same as usability validation.22:10 – Design Inputs vs. Design Outputs: The "Blueprint and the House" analogy for FDA submissions.25:40 – The impact of the "Use Environment": Testing for movement in ambulances and lighting in radiology suites.Quotes"The FDA doesn't put things out there just to have a good time... If they've made human factors a requirement and you're treating it as a 'suggestion,' you're giving yourself enough rope to hang yourself." - Staci Miller"People are obsessed with the product themselves—the design outputs. But the FDA wants to see the design inputs. They want to see the blueprints of how you built that house, not just the wallpaper." - Staci MillerTakeawaysPremeditation is Key: If you intend to use clinical trial data for HF validation, it must be planned in the protocol from the start; you cannot retroactively claim clinical data satisfies usability requirements.Map User Groups Early: Distinguish clearly between primary and secondary users. Bloating user sets without explaining how or why they engage with the device complicates your risk profile.Environment Matters: Documentation must account for the physical "10,000-foot view," including noise, lighting, and motion (e.g., an ambulance), as these are often where critical use errors occur.HF is Risk Management: Human factors should not live in a silo. It must align with the scales of harm (negligible to catastrophic) defined in ISO 14971 and work in tandem with Quality and Regulatory teams.ReferencesISO 14971: The global standard for the application of risk management to medical devices.FDA Human Factors Guidance: The primary document outlining expectations for usability testing and documentation.Etienne Nichols: LinkedIn ProfileMedTech 101: URRA vs. uFMEAThink of a uFMEA (User Failure Mode and Effects Analysis) like a car manufacturer looking at an old model to see why the brakes failed in the past—it relies on known data to fix specific parts.A URRA (Use-Related Risk Analysis) is like teaching someone to drive a brand-new type of vehicle (like a spaceship) for the first time. Since you don't have "crash data" yet, you have to carefully map out every single step the pilot takes and imagine every possible way they could push the wrong button in the heat of the moment.SponsorsGreenlight Guru: This episode is brought to you by Greenlight Guru, the only quality management platform designed specifically for the medical device industry. Whether you need to manage your QMS to stay compliant with ISO 14971 or streamline your clinical data through their EDC solutions, Greenlight Guru helps you move faster with less risk.Feedback Call-to-ActionWe want to hear from you! Do you have questions about your specific regulatory pathway or a topic you'd like us to cover? We provide personalized responses to every listener who reaches out. Send your thoughts, reviews, or suggestions to podcast@greenlight.guru.
Dave Rosa, CEO and President of NeuroOne, medtech entrepreneur, board member and former executive at St. Jude Medical, Boston Scientific and C.R. Bard. With three decades in medical devices and more than $200 million raised, Dave brings a rare mix of operator, inventor and capital markets experience to the future of neurotechnology and pain care.In this episode, we unpack one of the biggest mistakes medtech companies make: building technology without enough real-world user feedback. Dave explains why innovation for the sake of innovation often fails, especially in larger companies, and why the best products are shaped by how physicians and patients actually use them. We also explore NeuroOne's unique approach of combining diagnostics and therapeutics through the same electrode, and why that kind of multifunctional platform thinking can be both clinically powerful and commercially strategic.A major theme in this conversation is regulatory strategy. Dave walks through NeuroOne's deliberate “diagnostic first, therapeutic second” FDA pathway, explaining why starting with an easier regulatory indication can de-risk the technology, shorten timelines and create a stronger platform for later therapeutic claims. We also discuss the value of reusing the same generator across multiple indications, how founders often wait too long to engage with FDA, and why platform leverage matters from both a business and development perspective.We also go deep on chronic pain and lower back pain. Dave shares why today's pain solutions often fall short, how different triggers require different treatment approaches, and where technologies like ablation, stimulation and smarter electrode design could shift outcomes. He also highlights how seemingly small user-experience issues, like frequent recharging, can destroy patient adherence and wipe out billions in company value.Timestamps[00:00:08] Why MedTech Companies Fail When They Ignore Real User Feedback[00:02:04] Innovation vs Iteration: When “New” Adds No Real Value[00:02:22] Combining Diagnostics and Therapeutics With the Same Electrode[00:03:52] Why NeuroOne Chose a Diagnostic-First FDA Strategy[00:05:21] Pain Management Today: Ablation, Stimulation and Complex Back Pain[00:08:21] What Is Fundamentally Broken in Lower Back Pain Solutions[00:09:26] How Small Patient Frictions Can Destroy Adoption and Valuation[00:11:11] The Power of Reusing the Same Generator Across Multiple Indications[00:13:00] The FDA Mistake Many Founders Still Make[00:21:15] Where Neurotechnology and Pain Management Are Heading NextConnect with Dave - https://www.linkedin.com/in/daverosa/Learn more about NeuroOne - https://nmtc1.com/Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwalSubscribe to the Podcast
Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.6, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – smaller companies consider European expansion under MFN; Pfizer CEO on FDA vaccine decisions; what does big pharma want from CRDMOs in AI age; neuroscience funding poised for comeback; and UCB's big China deal. Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-N3WEPHD34BHGBGRM5BNJPTS2NY/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月6日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 中小型企业考虑在最惠国待遇下拓展欧洲市场；辉瑞CEO谈FDA疫苗审批决策；人工智能时代大型药企对CRDMOs有何期待；神经科学研究资金蓄势复苏；优时比与中国达成重大合作。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-N3WEPHD34BHGBGRM5BNJPTS2NY/ Playlist: on.soundcloud.com/gnr7PaOwflNKiAO7QX
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant events and trends shaping the industry landscape, offering insight into the dynamic interplay between scientific innovation, regulatory challenges, and strategic growth.Starting with the recent departure of Vinay Prasad from the U.S. Food and Drug Administration, particularly from his role as director of the Center for Biologics Evaluation and Research (CBER). Prasad's tenure, though brief, left an indelible mark characterized by controversy and debate over regulatory decisions. His leadership coincided with significant advancements in biologics and gene editing technologies, like CRISPR, highlighting the complexities in balancing innovation with safety standards. Under Prasad's guidance, the FDA faced challenges in navigating these rapid advancements while maintaining rigorous oversight to ensure that new therapies are both effective and safe for public use. Prasad's resignation signals potential shifts in regulatory philosophy at CBER. The biotech industry is watching closely to see how new leadership will influence ongoing and future evaluations of biologics. The change presents an opportunity to reassess how regulatory bodies can better adapt to scientific advancements while ensuring that patient safety remains paramount. The issues faced during Prasad's tenure underscore the need for transparent decision-making and open communication with stakeholders, which are vital for maintaining trust in regulatory processes.Meanwhile, Pfizer has made a strategic entry into the Chinese obesity market with the approval of a GLP-1 drug developed alongside Sciwind Biosciences. This approval represents not only a significant step for Pfizer but also underscores a broader global focus on obesity management. The efficacy of GLP-1 receptor agonists in weight regulation has opened up new market opportunities, highlighting the growing importance of metabolic health solutions in addressing public health challenges.In other news, Johnson & Johnson's Tecvayli-Darzalex combination therapy has received its third national priority recognition from the FDA for treating multiple myeloma. This recognition reflects promising Phase 3 trial results and underscores the critical role of innovative combination therapies in improving outcomes for complex hematologic malignancies. The success of such therapies illustrates how targeted approaches can significantly enhance treatment efficacy and patient quality of life.Strategic acquisitions continue to reshape industry dynamics. Servier's $2.5 billion acquisition of Day One Biopharmaceuticals aims to strengthen its rare cancer portfolio, including a promising glioma drug, Ojemda. This move highlights Servier's commitment to addressing unmet needs in pediatric oncology and rare diseases, emphasizing a broader industry trend towards focusing on niche therapeutic areas with high potential impact.Regulatory activities are gaining momentum as well, with the FDA set to end a nine-month hiatus in advisory committee meetings by reviewing AstraZeneca's oral selective estrogen receptor degrader Truqa. As AstraZeneca seeks to enhance its oncology pipeline, this review signals ongoing innovation in hormone-based cancer therapies and reflects a renewed emphasis on bringing novel treatments to market efficiently.Additionally, Glenmark Pharmaceuticals has achieved a significant milestone with FDA approval for its generic version of GSK's asthma inhaler Flovent. This development exemplifies efforts to improve access to respiratory treatments by providing cost-effective alternatives to branded medications, potentially reducing healthcare costs while enhancing patient access.On an international scale, Taiwan has announced a substantial investment plan aimed at bolstering its drugSupport the show
From posting products nobody cares about to teaching 800,000 cedis worth of value on TikTok, and why the brutal truth about selling anything online is that no one cares about your camera, your shoes, or your feminine hygiene products unless you show them the problem it solves, how to use it, and why their life needs it right now, the entrepreneur who discovered that the woman selling products for 350 cedis was just posting pictures assuming everyone knew what it does when ladies had no idea because African homes don't teach feminine hygiene and parents don't sit you down to explain these things, the university graduate who went through problems herself and wished someone was there to help her understand how to take care of herself which created the drive to teach ladies what they need to know instead of just selling products, the TikTok strategy that made 800,000 cedis and more because she wasn't there to dance and fool around but to sit down and give explicit knowledge that celebrities, pastors' wives, and mothers never had, the haters who said she didn't make that money and her response of "I don't care, the money is in my account not yours, I made more than that" because when you know your product works and you're giving value you don't care what people say, the Alibaba journey where she taught herself how to order from China by playing on the app, watching YouTube videos, and learning without waiting for someone to sell her a course or sit her down because no one has your time, you should have your own time, the beginner advice to identify the problem your product solves first before you even think about suppliers or shipping because if you're selling anything you need to know what problem it solves and who your audience is, the FDA approval battles that became her biggest challenge when products come with one name but FDA changes it after she's already marketed it creating confusion, the ingredients research she does on every product because "if I didn't want to die I wouldn't want you to die" so she uses her own products and learns about what's inside them, the lab analysis costing 1,000 to 3,000 cedis and FDA registration for imported products at $500 proving you need money to do things right but you can start by reselling other people's products if you have knowledge about what you're selling, the camera example where posting "I'm selling a camera" means nothing but showing phone camera versus real camera quality, explaining why someone serious would choose the camera, demonstrating the value makes people care, the salon analogy that if you open a salon and don't know how to wash hair it will collapse because you just wanted money or had support but didn't have knowledge about salons, the internet wisdom where she doesn't care about gossip, doesn't go online looking for anyone's business, uses her time to learn instead of looking for gossip because anything you want to know is on YouTube, TikTok, free materials that people make available, the verified suppliers on Alibaba for beginners, the AKT shipping company she's used for years because they're reliable, the Turkey and China trips proving she's willing to travel and learn and build an international brand, the people who want to be taught before they take a step when sometimes you need to start, get the idea, play on the apps, watch videos, and figure it out yourself, the realization that when it comes to products you don't need to do your own production from the start but you need to know something about what you're selling because there are people who swallow when they're supposed to insert and insert when they're supposed to swallow, and why the ultimate truth is this: people are usually more focused on the money than the value they give which is where she picked her form because the woman selling for 350 was just posting assuming everyone knew what the product does when people didn't know, but when she came in teaching ladies how to take care of themselves and using the product in addition to that care, when she gave knowledge that African homes don't teach, when she showed up on TikTok not to dance but to educate, when she learned everything from YouTube and the internet without waiting for courses or teachers, when she researched ingredients and used her own products, when she didn't care about haters saying she didn't make 800K because the money was in her account proving her value was real, she wasn't just selling products, she was solving problems and teaching solutions, and that's the only way to build a business that lasts because no one cares about what you're selling until you show them why they need it. Guest: Charity Boateng Host: Derrick Abaitey
Check out host Bidemi Ologunde's new show: The Work Ethic Podcast, available on Spotify and Apple Podcasts.Email: bidemiologunde@gmail.comIn this episode, host Bidemi Ologunde explores the rapid rise of prediction and betting markets, and why more people are suddenly treating odds as a serious signal about the future. What is driving their mainstream adoption now? Why are platforms moving beyond sports into politics, economics, and war-risk speculation? And when markets start pricing everything from championship games to the possibility of conflict with Iran, are they revealing collective intelligence, or just turning uncertainty into entertainment?Sponsors and partners:Promeed: 100% mulberry silk pillowcases and bedding that feel incredibly soft, stay breathable, and are naturally gentle on hair and skin.SurviveX: professional-grade FSA/HSA eligible first aid and preparedness kits designed in Virginia, USA and produced in an FDA-registered facility.Alison US CA: Alison is the world's largest free online learning and skills-training platform, helping more than 50 million learners in 193+ countries build career-ready skills with 6,000+ free courses, certificates, and diplomas.eSign (iOS only): eSign is a clean, privacy-first document-signing app that works entirely on your device, letting you sign PDFs, DOCX files, images, and scans, edit and assemble pages, and export crisp 300 DPI PDFs in seconds, without accounts, cloud uploads, or compromising sensitive documents.Support the show
This week’s podcast summarizes some highlights in scientific research and includes a recognition of Rare Disease Week and actions taken by the FDA to ease the criteria for evaluating genetic therapies for rare genetic disorders, the best study to date on the mortality in autism, genetic prediction of outcome in individuals with a diagnosis, and Uta Frith’s commentary on the concept of “spectrum”. https://pubmed.ncbi.nlm.nih.gov/41773580 https://pubmed.ncbi.nlm.nih.gov/41651809 https://pubmed.ncbi.nlm.nih.gov/41661606 https://archive.ph/fPscR
On this episode of Vitality Radio, Jared sits down with Maggie Frank of CV Sciences to unpack the growing federal threat to hemp-derived CBD and low-dose THC products. With potential legislation that could dramatically restrict access as early as November 2026, this conversation explores what's at stake for consumers, retailers, and the natural health community. You'll learn what the proposed changes could mean for over-the-counter CBD products, and why responsible regulation—not prohibition—is the path forward. Jared and Maggie also discuss the importance of consumer education, the role of the endocannabinoid system, and how adults can make informed choices about plant-based wellness options. If you care about supplement freedom, access to hemp products, and protecting natural health choices, this is an episode you won't want to miss.Products:CBD Products - Visit Vitality Nutrition in Bountiful, Utah or call us to order 801-292-6662Additional Information:U.S. Hemp RoundtableVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
In this groundbreaking episode of the Tick Boot Camp Podcast, we interview Dr. Jayakumar Rajadas, a Stanford Medicine researcher who has discovered multiple breakthrough therapeutic candidates for Lyme disease, Babesia, and Bartonella. His work includes the discovery of Disulfiram's effectiveness against Lyme and Babesia, Azlocillin's potent activity against Lyme and Bartonella, and advanced targeted drug-delivery systems designed to preserve the gut microbiome. Dr. Jay's research has been featured in TIME Magazine (Azlocillin) and Forbes (Disulfiram), and connects deeply with the work of leading Lyme researchers, including Dr. Monica Embers (Tulane), Dr. Kim Lewis (Northeastern), Dr. Kenneth Liegner, and Dr. Brian Fallon (Columbia University). This interview delivers hope, science, and unprecedented detail on what may become the next generation of Lyme disease treatments. Key Topics Covered 1. How the Stanford Tick Initiative Sparked a New Era of Drug Discovery In 2012, Stanford launched a major initiative in response to community demand for better Lyme treatments. Dr. Rajadas was selected to lead drug development, focusing specifically on persistent/chronic Lyme disease, where few researchers were working. 2. Understanding Borrelia: Active vs. Stationary Forms & Why Chronic Lyme Persists Dr. J explains the three key survival modes of Borrelia burgdorferi: Active Phase The bacteria are replicating and metabolically active. Easier to kill with standard antibiotics. Stationary Phase Bacteria reach population limits and slow down growth. Represents early persistence mechanisms. Persister Forms Triggered by stressors like antibiotics (e.g., doxycycline). Bacteria fold into round bodies, spiral forms, or compact “cement-like” protective balls. These forms: Shut down metabolic pathways Resist penetration Survive antibiotic exposure Why Doxycycline Can Fail Doxycycline can induce persisters, causing Borrelia to form impenetrable protective shells rather than die. This is why many patients initially feel better, then relapse. 3. Disulfiram (Antabuse): Lyme + Babesia Breakthrough Featured in Forbes One of the biggest scientific shocks of the last decade: Discovery Through Stanford's high-throughput screening of FDA-approved drugs, Disulfiram emerged as a top hit. Clears Borrelia (including persistent forms) Clears Babesia — a major advantage over standard antibiotics Does NOT harm the gut microbiome Is already FDA-approved and widely used for alcohol aversion therapy Highly potent but requires careful dosing due to side effects in inflamed patients. Why Some Patients Improve, and Others Suffer Chronic Lyme patients already have heightened inflammation. Disulfiram is a powerful molecule whose polymorphic forms behave differently in different people. His lab developed: Less toxic formulations Buccal & sublingual delivery systems Rectal delivery options These may reduce neuropsychiatric side effects reported by some patients. Clinical Connections Dr. Kenneth Liegner pioneered clinical use and published cases Dr. Brian Fallon conducted NIH-listed clinical trials. Many clinicians now use Liegner's protocols. Real-world example: Matt shares the story of Brooke Stoddard (Generation Lyme), who regained his life after Disulfiram treatment under Dr. Liegner. 4. Azlocillin: The Antibiotic That TIME Magazine Called a Gamechanger If Disulfiram is the Lyme and Babesia weapon, Azlocillin may be the frontline tool for Lyme and Bartonella. Why Azlocillin Is Revolutionary Eradicates both active and persister forms of Borrelia. Destroys doxycycline-induced “cement ball” persisters by drilling into their vulnerable cell-wall synthesis pathways. Proven effective against Bartonella when paired with azithromycin, based on research by Dr. Monica Embers (Tulane) . The Cell-Wall Vulnerability Breakthrough Persisters STILL must maintain minimal cell-wall synthesis to survive. Azlocillin exploits this tiny vulnerability: It penetrates the protective sphere Breaks the “cement wall” Forces the bacteria out of hibernation Kills them rapidly This discovery is one of the biggest scientific leaps in Lyme research in a decade. The Delivery System That Protects the Gut Microbiome Azlocillin is extremely hydrophilic, making absorption difficult.Dr. Jay fixed this by creating: A magnesium-lipid nanoparticle formulation Designed to release in the upper intestine Avoiding the colon (where most microbiome lives) This allows: High bloodstream absorption Minimal microbiome damage Oral availability of a drug previously only available via IV Why Azlocillin May Be Better Than Disulfiram Hits Borrelia + Bartonella Stronger anti-inflammatory effects No polymorphism issues Fewer side effects Potent against persisters A company is preparing to bring his oral formulation to clinical trials by next year. 5. Loratadine (Claritin): The First Clue from 2012 Before Disulfiram and Azlocillin, Dr. Jay's lab identified Loratadine (Claritin) as a manganese transporter inhibitor of Borrelia. Why it mattered: Borrelia uniquely relies on manganese, not iron. Blocking manganese uptake may weaken the bacteria. The discovery went viral, with many patients reporting improvement even at OTC doses—though the binding affinity was weak. This project introduced the concept of drug repurposing for Lyme to the scientific community. 6. Melittin (Bee Venom) — The Micro-Needle Patch Alternative Bee venom therapy is widely used in the Lyme community, but risks stings and allergic reactions. Dr. J is developing: Melittin micro-needle patches Delivering the active peptide without stinging Using dissolvable, painless needles A safe, controlled, pharmaceutical-grade delivery approach This could modernize bee venom therapy and make it more accessible. 7. Mechanism of Brain Fog & Fatigue in Lyme: A Major Breakthrough Dr. Jay's lab published a neuroscience paper demonstrating: Outer Surface Protein (Osp) Nanoparticles Borrelia sheds lipid-coated outer membrane particles. These form stable nano-vesicles that: Enter the bloodstream Cross into the brain Cause mitochondrial dysfunction Reduce ATP production Result: Brain Fog, Fatigue, Cognitive Dysfunction This explains why neurological Lyme can persist even after bacterial levels drop. This work ties strongly to ongoing research at Columbia University under Dr. Brian Fallon. 8. Collaborations With World Leaders in Lyme Research Dr. J's research intersects with: Dr. Kim Lewis (Northeastern University) Reproduced and validated Disulfiram findings publicly. Helped launch interest in persister-killing therapies. Dr. Monica Embers (Tulane University) Demonstrated Azlocillin + Azithromycin effectiveness against Bartonella. One of the world's foremost experts in persistent infection models. Dr. Kenneth Liegner Early clinical pioneer of Disulfiram therapy. Published stunning recovery cases. Dr. Brian A. Fallon (Columbia University) Leading psychiatrist specializing in post-treatment Lyme. Conducted planned Disulfiram clinical trials. These collaborations form a powerful network accelerating treatment development. 9. New Anti-Inflammatory Discoveries: Galangin & More Dr. Jay recently co-authored a 2025 paper on: Galangin (Thai ginger rhizome extract) Which may reverse cardiac inflammation and fibrosis His team is also exploring other nutraceutical molecules for chronic inflammation relief in Lyme patients. 10. Dr. Jay's Personal Story of Illness and Hope He reveals for the first time: He was diagnosed with Stage 3 Multiple Myeloma Lost the ability to walk Suffered unbearable pain After cutting-edge therapies and research, he is now in full remission His message to Lyme patients: “There is ALWAYS hope.”
U.S. President says Iran will be hit hard on Saturday, as he weighs new targets. One week into the Iran war, the risks for the U.S. and the administration multiply. Tehran apologizes to its Gulf neighbors but strikes escalate. Hundreds of thousands flee Israeli bombs in Beirut. Russian President Vladimir Putin calls for an immediate end to the Iran war. And the FDA vaccines chief will step down in April. Plus, Formula One enters a new era. Listen to the Morning Bid podcast here. Sign up for the Reuters Econ World newsletter here. Listen to the Reuters Econ World podcast here. Find the Recommended Read here. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices
Links to All Articles Mentioned:https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-riskshttps://www.fda.gov/media/174456/downloadRFK Jr. just appeared on the Joe Rogan podcast and peptides were front and center. Dr. Matt Kaeberlein breaks down the conversation in real time, fact-checking claims about peptide efficacy, FDA regulation, and the growing black market for compounded peptides.What does the science actually say? What did RFK get right and where did the conversation miss the mark? Dr. Kaeberlein cuts through the noise with a scientist's lens, covering everything from BPC-157 to GLP-1 agonists to the FDA's Category 2 bulk drug substances list.If you're navigating the peptide space and want clarity over hype, this one's for you.Timestamps:00:00 — Intro & Episode Overview01:06 — RFK on Joe Rogan: The Peptide Conversation Begins02:06 — First Fact Check: "We Know Peptides Work"03:50 — GLP-1 Agonists: The Exception, Not the Rule05:05 — RFK's Personal Peptide Experience06:32 — The FDA's Bulk Drug Substances List Explained08:32 — FDA Category 2: What It Actually Means09:21 — The Peptides That Were Banned From Compounding10:18 — Did the FDA Consider Safety? Here's What the Data Says12:03 — Real Cases of People Harmed by Compounded Peptides13:40 — Can the FDA Consider Efficacy? Reading Directly From the Guidelines15:44 — The Peptide Black Market: How It Emerged17:54 — Will Reversing the Ban Actually Fix the Problem?19:20 — RFK's Push to Move 14 Peptides Back to the Bulk List20:16 — Dr. Kaeberlein's Take: Informed Patient Access Matters21:51 — Who Created the Black Market?22:46 — What Would Actually Help: Funding Real Clinical Trials23:36 — Final Thoughts & Call to Action
In episode 2018, Jack and Miles are joined by comedian and host of Abolish Everything, Chandler Dean, to discuss… Noem’s TERRIBLE Week, RFK Jr vs Dunkin, You Can Blame Big Oil and Big Golf For Daylight Saving Time and more! Tillis to Noem: "Those are bad decisions made in the heat of the moment, not unlike what happened in Minneapolis." Rep. Kamlager-Dove enters articles in the congressional record with headlines like, "Lewandowski taking out trash at Noem's DC home" and "ICE Barbie's mile high private chamber with alleged lover exposed" Noem Gets Grilled Over Government Contracts RFK Jr vs Dunkin RFK Jr. took aim at Dunkin'. Mass. residents threatened revolts Your favorite iced summer coffee could contain 46 teaspoons of sugar — the same as drinking 5 cans of Coke British Columbia Will Change Clocks on Sunday for the Last Time 7 Things to Know About Daylight Saving Time The dark side of daylight saving time B.C.'s premier is celebrating the move to permanent daylight time. Others aren't so sure Bill To Make Daylight Saving Time Permanent Stalls In Congress Again What Happened the Last Time the U.S. Tried to Make Daylight Saving Time Permanent? The Real Reason Why Daylight Saving Time Is a Thing The stakeholders of daylight saving time Golf industry tees up fight to keep daylight saving time The business of Daylight Saving Time, from golf to oil 9 Things You Probably Don't Know About Daylight Saving Time The Reasoning Behind Changing Daylight-Saving Is permanent daylight saving time a good idea? Lobbyists, lawmakers and sleep experts are split. What would ‘half-daylight saving time’ look like? LISTEN: Mesa Mesa by YuufSee omnystudio.com/listener for privacy information.
Parmesan cheese scandal exposed: many “100% Parmesan” brands contain up to 20% wood shavings, sawdust, and lint—FDA-approved fillers you're eating on spaghetti and meatballs. Opie Radio podcast with Opie and Ron the Waiter dives into the gross truth behind store-bought Parmesan cheese, fake severed thumb restaurant scams, pubic hair on pizza slices in NYC, Trump's Oval Office religious leaders prayer circle, World War III religious war theories for Armageddon and Jesus return, AI taking jobs and possibly bringing back dinosaurs, Dee Snider health issues ending Twisted Sister tours, plus classic FU Friday rants on soggy paper straws and more. Raw, humorous, no-BS conversations with real talk and storytelling. Subscribe for unfiltered episodes every week—new Opie Radio podcast drops Fridays. Leave a review and tell us what bothers you this week!
This hidden ingredient in junk food is quietly destroying your health. Uncover the harmful food additives and food industry secrets that leave you sick, yet still hungry for more. Learn how these hidden junk food ingredients sabotage your gut health and how you can avoid them starting today.Download Dr. Berg's Free Daily Health Routine: https://drbrg.co/45qtO07This dangerous ingredient in junk food acts as a detergent in your gut. This toxic food additive destroys the protective layer that lines your digestive tract, similar to the way dish soap removes grease from a pan. Once this protective layer is gone, you can develop a leaky gut, allowing toxic food additives, bacteria, and partially digested food into your bloodstream.Harmful food additives are often hiding in ice cream, chocolate, salad dressing, plant-based milk, bread, peanut butter, coffee creamer, mayo, baby formula, and the list goes on! This toxic ingredient is found in 60% of all packaged foods, and goes by names like polysorbate 80, carboxymethylcellulose, and carrageenan. These hidden ingredients in junk food are called emulsifiers. Emulsifiers force oil and water to mix so that the processed food appears smoother or creamy in texture and has a longer shelf life. There is a thick layer of mucus that coats the inside of the intestines, which acts as a built-in protective mechanism for your gut. Emulsifiers dissolve this protective layer over time, allowing bacteria to enter your bloodstream. Your immune system tags them as pathogens, causing an immune reaction and chronic gut inflammation. Gut health directly affects your cognitive function. If you have gut inflammation, you might experience brain fog, sluggishness, and the inability to think clearly after eating. In animal studies, polysorbate 80 caused metabolic syndrome, weight gain, blood sugar problems, and altered gut bacteria. Although no long-term human studies have been published, a human trial published in 2024 found that participants had altered gut microbiomes after just 2 weeks of eating emulsifiers. In the US, food additives can be self-classified as generally recognized as safe (GRAS). Junk food companies do not have to submit long-term human trials to the FDA. The easy solution to this problem is to avoid ultra-processed foods. Instead of focusing on willpower and discipline, avoid buying junk foods altogether. Dr. Eric Berg DC Bio:Dr. Berg, age 60, is a chiropractor who specializes in Healthy Ketosis & Intermittent Fasting. He is the Director of Dr. Berg Nutritionals and author of the best-selling book The Healthy Keto Plan. He no longer practices, but focuses on health education through social media.Disclaimer: Dr. Eric Berg received his Doctor of Chiropractic degree from Palmer College of Chiropractic in 1988. His use of “doctor” or “Dr.” in relation to himself solely refers to that degree. Dr. Berg is a licensed chiropractor in Virginia, California, and Louisiana, but he no longer practices chiropractic in any state and does not see patients, so he can focus on educating people as a full-time activity, yet he maintains an active license. This video is for general informational purposes only. It should not be used to self-diagnose, and it is not a substitute for a medical exam, cure, treatment, diagnosis, prescription, or recommendation. It does not create a doctor-patient relationship between Dr. Berg and you. You should not make any change in your health regimen or diet before first consulting a physician and obtaining a medical exam, diagnosis, and recommendation. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.
What happens when one of the most disciplined bodies in the world can't do the one thing everyone assumes it should? On this episode -- one of our most downloaded of all time -- Ali sits down with Mathilde Froustey, principal dancer at the San Francisco Ballet and widely considered one of the most extraordinary dancers in the world.Born in Bordeaux, France, Mathilde began dancing at just nine years old, training at the prestigious Marseille National School of Ballet and the Paris Opera Ballet School before rising to the top of the international ballet world. Onstage, her body is her instrument — powerful, precise, and seemingly unstoppable. But behind the curtain, Mathilde has been fighting battles that almost no one in the dance world talks about. In this candid and emotional conversation, she opens up for the first time about her experience with infertility — a subject she says remains deeply taboo in professional dance. Mathilde shares what it was like to go through IVF while performing at the highest level, navigating intense body scrutiny, and hearing painful comments about her appearance during one of the most vulnerable periods of her life. She also talks about her past struggle with an eating disorder, the pressure dancers face to maintain a certain body type, and the silent toll of trying to build a family inside a culture that rarely makes space for it.“In the dance world, infertility is a taboo subject,” Mathilde says.Not anymore.This is a powerful conversation about perfection, pressure, and what it means to reclaim your body — both onstage and off.EPISODE SPONSORS: THE WORK OF ART BOOK SERIESAli's Children's Book Series about IVF, IUI and Family Building Through Assisted Reproductive Technology https://www.infertileafgroup.com/booksThe 3-book bundle is now just $49 (normally $79)!The latest book in the Work of ART series, “You Are a Work of ART," is for every kiddo born through ART -- and the people who love them.PHERDALIG: @pherdal_sciencePherDal is the world's first and only FDA-cleared, sterile, at-home insemination kit designed to help people build their families in the comfort of home. Created by parents who've been there, PherDal is safe, simple, and affordable—putting more options in your hands as you grow your family. Explore at PherDal.com.Go to PherDal.com today and use code INFERTILEAF for $10 off.BELIIG: @belibabywww.belibaby.com Are you thinking about growing your family? Whether you're just starting to plan or are actively trying to conceive, preconception health is key. Beli has vitamins to help both women and men optimize their health before pregnancy. With essential nutrients like Folate, Iodine, and Zinc, Beli ensures your body is ready for this exciting next step. Give yourself and your future baby the best foundation for a healthy start.Visit Belibaby.com today and use code IAF15 for 15% off your first order. Our Sponsors:* Sign up and get 10% off at BetterHelp dot com. Your emotional wellbeing matters. Find support and feel lighter in therapy. Support this podcast at — https://redcircle.com/infertile-af-infertility-and-modern-family-building-through-art/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
uniQure is a business that develops gene therapies. uniQure's AMT-130 is currently in the headlines. This podcast episode attempts to present the Huntington's Disease community's arguments for why the FDA should work collaboratively to design a palatable drug trial. Last week the FDA told uniQure that AMT-130 would be subject to a double blind, Phase 3, randomized controlled study. While the scientific basis for that request is sound in most cases, the Huntington's Disease community argues that path is overly burdensome; perhaps impossible. This episode cites:Dr. Sung - https://www.youtube.com/watch?si=VhMQaFAZRvQA5NRj&t=62&v=mwEEJ91LeJY&feature=youtu.beSr. Sarah Tabrizi - https://www.youtube.com/watch?v=wKj1JRfJBRE&t=356sDr. Ed Wild - https://www.spreaker.com/episode/uniqure-update-with-dr-ed-wild--67900959FDA papers - External Control Guidance https://www.fda.gov/media/122425/downloadUse of Bayesian Statistics - https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-bayesian-methodology-clinical-trials-drug-and-biological-productsSenate Committee on Aging - https://www.youtube.com/watch?v=yLm1SltbRxw&t=2702sSponsorship InformationThank you to Trata for sponsoring the show.If you're listening to this podcast, you'll like Trata. Trata is buyside to buyside conversations on individual stocks. Trata makes finding a bull or bear on any stock as easy as clicking two buttons. Over 125 funds globally contribute that collectively cover 2000+ tickers. Trata raised over $3mm coming out of Y Combinator. Before you would track 13Fs, now you can understand what funds are actually thinking. You can join as a lurker or you can join as a contributor and Trata will pay you hundreds of dollars per call. For a free trial, go to trytrata.com/brew OG Sponsor Shoutout!Thank you to Fiscal.ai for sponsoring the show. DISCOUNT INFO: If you use the affiliate link fiscal.ai/brew, you will automatically get 2 weeks of Fiscal Pro for Free and if you find that you want to upgrade, my link will get you 15% off any paid plans. About Fiscal.aiFiscal.ai is the complete modern data terminal for global equities.The Fiscal.ai platform combines a powerful user experience with all the financial data capabilities that professional investors need. Users get up to 20 years of historical financials for all stocks globally that they can easily chart, compare, or export into their own models. And unlike legacy data terminals where it can take hours or even days, Fiscal.ai's data is updated within minutes of earnings reports. Fiscal.ai also tracks all the company-specific Segment & KPI data so you don't have to. Like to track Amazon's Cloud Revenue? They've got it.How about Spotify's premium subscribers? Or Google's quarterly paid clicks?They've got all of it.
Dr. Marc Pietropaoli is an orthopedic surgeon and founder of Victory In Motion, home of Knee Repair, NOT Knee Replacement®. A former fellow of Dr. James Andrews, he has spent more than 25 years advancing regenerative and non-operative orthopedic care. He was the first surgeon in the world to perform an FDA-indicated BEAR ACL repair outside of clinical trials. His mission is bold: make the world Knee Replacement Free by 2043. In this episode, Dr. Mark Pietropaoli shares how he went from traditional orthopedic surgery to pioneering regenerative approaches like stem cells, PRP, laser therapy, and his Victory Method to help people repair knees instead of getting knee replacements. RESOURCES: Learn more about Dr. Pietropaoli here: http://www.victoryinmotion.com Instagram: @drmarcpietropaoli Get his book "Repair Not Replace" here: https://amzn.to/4uclnk3 Get 10% off Peluva minimalist shoe with coupon code COACHTARA here: http://peluva.com/coachtara CHAPTERS: 00:00 – Intro 01:52 – Sponsor: Peluva minimalist shoe ad 03:47 – Dr. Pietropaoli's background 04:35 – Witnessing a knee replacement and asking "Isn't there a better way?" 09:12 – Training, indoctrination, and early exposure to regenerative tools (laser, PRP, PT, nutrition) 21:24 – Stem cells, aging joints, and why knees break down over time 48:51 – The Victory Method, clarity day, and full-body assessment process 53:19 – Testing, imaging, goal‑setting in one visit 53:57 – Virtual care, state licenses, and working with out‑of‑town patients 58:30 – Where to find Dr. Pietropaoli WORK WITH TARA: Are You Looking for Help on Your Wellness Journey? Here's how Tara can help you: TRY TARA'S APP FOR FREE: http://taragarrison.com/app INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats SOCIAL MEDIA: Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv If you loved this episode, please leave a review! Here's how to do it on Apple Podcasts: Go to Inside Out Health Podcast page: https://podcasts.apple.com/us/podcast/inside-out-health-with-coach-tara-garrison/id1468368093 Scroll down to the 'Ratings & Reviews' section. Tap 'Write a Review' (you may be prompted to log in with your Apple ID). Thank you!
Broadcast from KSQD, Santa Cruz on 3-05-2026: Dr. Dawn demonstrates how to critically read a science paper using a widely-publicized study claiming adolescent cannabis use causes psychotic, bipolar, and anxiety disorders. She identifies multiple methodological problems: only 5.7% of Kaiser adolescents admitted cannabis use versus 11.2% in anonymous national surveys, suggesting massive underreporting; the study conflates any use with heavy use; and with 463,000 participants, trivially small differences become statistically significant but clinically meaningless. She proposes reverse causation—that prodromal schizophrenia symptoms may drive teens to self-medicate with cannabis rather than cannabis causing psychosis. The study also included "disruptive behavior disorder" diagnoses that lack rigorous criteria, and she notes diagnostic codes are sometimes chosen for insurance reimbursement rather than accuracy. While acknowledging high-dose THC before age 16 may affect brain development, she concludes the headlines claiming causation are not supported by the actual findings. Dr. Dawn discusses how aquaculture—now producing 60% of fish consumed globally—has become a breeding ground for antibiotic-resistant pathogens. More antibiotics per kilogram are used in fish farming than in any other animal agriculture, with drugs dissolving into water and sediment where bacteria develop resistance. One study found antibiotic-resistant bacteria in over 80% of shrimp species tested across multiple countries. Through horizontal gene transfer, these resistance genes spread to human pathogens—a 1991 Latin American cholera outbreak affecting nearly a million people may have acquired drug resistance from Ecuadorian shrimp farms. Dr. Dawn reports that the FDA rejected Moderna's mRNA flu vaccine application without even reviewing it, despite trials of 41,000 people showing it was 27% more effective at preventing illness and 29% more effective at preventing hospitalization than existing vaccines. She attributes this to politicized anti-mRNA bias lacking scientific basis, noting that venture capital investors like Blackstone (who invested $750 million) will now avoid vaccine development, effectively handing this critical technology to other countries. Dr. Dawn describes the "wellness industrial complex"—pharmaceuticals, tech, testing companies, and health influencers creating content that pathologizes normal behaviors. YouTube health videos have amassed 200 billion views, and 30% of British respondents now get medical advice from AI chatbots. She cites a 400% increase in British adults seeking ADHD diagnoses, noting that analysis of top TikTok ADHD videos found less than 50% accurately reflected actual symptoms. Many influencers receive undisclosed payments to mention products, and the U.S. and New Zealand are the only countries allowing direct-to-consumer drug advertising. A caller asks about navigating Medicare after their Advantage plan was terminated with no local providers accepting remaining plans. Dr. Dawn explains that Medicare Advantage companies took extra government payments meant for wellness programs but didn't build them, and are now exiting markets as costs rise. She recommends contacting Gray Bears or AARP for free Medicare navigation assistance and suggests exploring regular Medicare with a secondary plan or direct-pay practices. /li>
If you have chronic hives and antihistamines aren't helping, there's a new treatment option to know about. In this episode of The Itch Review, we spotlight "Remibrutinib in Chronic Spontaneous Urticaria" published in The New England Journal of Medicine, March 2025. This article looks at the REMIX trials, which tested whether remibrutinib, a BTK inhibitor, can help adults whose chronic spontaneous urticaria (CSU) is not controlled by antihistamines alone. Remibrutinib works differently from antihistamines. Instead of blocking histamine after it's released, it stops mast cells from releasing those itch-causing chemicals in the first place. The FDA approved remibrutinib in September 2025. What we cover in our episode about the REMIX trial: Understanding CSU: Chronic spontaneous urticaria causes itchy hives and swelling for more than 6 weeks with no clear trigger, and antihistamines don't work for everyone. How remibrutinib works: This BTK inhibitor stops mast cells from releasing chemicals like histamine, rather than blocking histamine after it's already released. Why do two identical trials: Running the same study twice (REMIX-1 and REMIX-2) with different patients helps prove the results are real, not a fluke. Key results: About half of patients reached well-controlled disease, and about 1 in 3 became completely clear of hives and itch. Safety and side effects: Petechiae (tiny dots of bleeding under the skin) were the main thing to watch for, but most cases were mild and went away on their own. DOWNLOAD THE INFOGRAPHIC More resources about chronic hives Chronic Spontaneous Urticaria - Allergy & Asthma Network Chronic Urticaria Toolkit What are hives? All episodes on urticaria *********** The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference. *********** Made in partnership with The Allergy & Asthma Network. Thanks to Novartis for sponsoring today's episode. This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
In today's episode, we welcomed Saad Z. Usmani, MD, MBA, FACP, FASCO, to discuss the significance of the January 2026 FDA approval of daratumumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (VRd) for the treatment of adult patients with newly diagnosed multiple myeloma who are not eligible for autologous stem cell transplant (ASCT).Usmani is chief of Myeloma Service at Memorial Sloan Kettering Cancer Center in New York, New York, and the recipient of the 2025 Giants of Cancer Care award for multiple myeloma.In the exclusive interview, Dr Usmani explained the clinical implications of the regulatory decision that expanded the indication for daratumumab plus VRd to the transplant-ineligible setting, detailed the pivotal data from the phase 3 CEPHEUS trial (NCT03652064) that supported the approval, and provided context for treatment strategies with this regimen in clinical practice.
Check out host Bidemi Ologunde's new show: The Work Ethic Podcast, available on Spotify and Apple Podcasts.Email: bidemiologunde@gmail.comIn this episode, host Bidemi Ologunde sits down with JoJo Kalita, Vice President of Partnerships and ACTOverse at ACTO. JoJo is a tech leader with over a decade of experience across Operations, Customer Success, and now Partnerships, where she's helping shape the AI landscape through collaborations with global industry leaders, including work in life sciences and beyond. How do you build operational systems that drive efficiency without losing the human touch? What does "customer obsession" look like when your job is no longer customer-facing, but partnership-driven? And how can emotional intelligence turn mentorship into a ripple effect of real impact? JoJo shares the lessons behind her relationship-first leadership style, her approach to choosing the right partners, and how to leverage technology in ways that stay grounded in empathy, clarity, and outcomes.Sponsors and partners:Promeed: 100% mulberry silk pillowcases and bedding that feel incredibly soft, stay breathable, and are naturally gentle on hair and skin.SurviveX: professional-grade FSA/HSA eligible first aid and preparedness kits designed in Virginia, USA and produced in an FDA-registered facility.Alison US CA: Alison is the world's largest free online learning and skills-training platform, helping more than 50 million learners in 193+ countries build career-ready skills with 6,000+ free courses, certificates, and diplomas.eSign (iOS only): eSign is a clean, privacy-first document-signing app that works entirely on your device, letting you sign PDFs, DOCX files, images, and scans, edit and assemble pages, and export crisp 300 DPI PDFs in seconds, without accounts, cloud uploads, or compromising sensitive documents.Support the show
This is a Vintage episode from 2007.Why This Episode MattersBaking isn't magic; it's chemistry. Gail explains ingredient function so you can so you can bake with intention rather than habitLearn how to substitute intelligently (yogurt for buttermilk, butter vs lard, etc.) without sabotaging structure The episode is packed with practical fundamentals: tools, pantry essentials, pie crust fat choices, and why ice cream flavors must be stronger before freezing.The BanterMark Pascal and Francis Schott open with a recap of a “Duckathlon” with other restaurants— assessing steak, cheese, birds, and brandy. They then pivot hard into food-label transparency and why consumers should be allowed to know what's been done to their food.The ConversationGail Sokol joins to explain why baking differs from cooking and what you need to know. She breaks down how acid-base reactions relate to texture and how her book teaches technique. They also get into real-world home baking: what tools matter, what belongs in your pantry, why lard makes flaky crust, and how to make ice cream that doesn't taste flat once frozen. (Caution: May require sampling.)Timestamps0:00 – “Duckathlon” recap: IDing steak, cheese & mystery birds4:40 – FDA labeling debate: transparency vs “choice” rhetoric9:30 – Gail Sokol joins: baking is science, leavening explained17:10 – Why her book teaches methods: visuals, steps, and understanding ingredient roles20:40 – Home baker essentials: mixer, bowls, spatulas, & whisks 24:00 – Pie crust: butter vs lard; why blends work29:40 – Ice cream fundamentals: pre-chilling, flavor “punch,” serving temperatureGuest BioGail Sokol is an award-winning professional baker and college-level baking instructor. She's the author of About Professional Baking: The Essentials, a fundamentals-first baking guide focused on methods, ingredient function, and technique.Show InfoAbout Professional BakingBy Gail SokolGail's site https://chefgailsokol.com/Join us on March 12 for a wine dinner with BallettoClick below for more info:https://www.stageleft.com/event/31226-balleto-winemaker-dinner-w-anthony-beckman/ Become a Restaurant Guys' Regular!https://www.buzzsprout.com/2401692/subscribeMagyar Bankhttps://www.magbank.com/Withum Accounting https://www.withum.com/restaurantOur Places Stage Left Steakhttps://www.stageleft.com/ Catherine Lombardi Restauranthttps://www.catherinelombardi.com/ Stage Left Wineshophttps://www.stageleftwineshop.com/ To hear more about food, wine and the finer things in life:https://www.instagram.com/restaurantguyspodcast/https://www.facebook.com/restaurantguysReach Out to The Guys!TheGuys@restaurantguyspodcast.com**Become a Restaurant Guys Regular and get two bonus episodes per month, bonus content and Regulars Only events.**Click Below!https://www.buzzsprout.com/2401692/subscribe
Cattitude - Cat podcast about cats as pets on Pet Life Radio (PetLifeRadio.com)
On this episode of Cattitude, Michelle Fern welcomes veterinarian Dr. Heather Davis, Director of Clinical Affairs and Veterinary Services for Pegasus, to discuss hypertrophic cardiomyopathy (HCM)—a surprisingly common heart disease that affects about 1 in 7 cats. Often called a silent killer because symptoms can go unnoticed until the disease is advanced, HCM is something every cat parent should know about. Dr. Davis explains what causes HCM, why certain breeds like Maine Coons, Ragdolls, and Sphynx cats may be at higher risk, and how veterinarians diagnose and manage the condition. She also shares a simple “breath test” cat owners can do at home to help detect early warning signs while their cat is sleeping. Plus, Michelle and Dr. Davis discuss new advances in veterinary medicine, FDA-approved treatments for feline heart disease, and the importance of working closely with your veterinarian instead of relying on “Dr. Google.” If you love your cat and want to stay proactive about their health, this informative episode is a must-listen.EPISODE NOTES: The 30-Breath Test That Could Save Your Cat's LifeBecome a supporter of this podcast: https://www.spreaker.com/podcast/cattitude-the-1-cat-podcast--6666768/support.
The founders of Hershey, Good Humor, Stouffer, Heinz, Kellogg, Kraft, and Birdseye, among others, were pioneers looking to bring clean, hygienic, healthy, and trustworthy products to a market saturated with the opposite. Each specialized in a product, be in chocolate, ice cream, prepared meals, ketchup, cereal, cheese, or frozen foods. Recently we have learned that the grandson of the inventor of Reeses's Peanut Butter cups, owned by Hershey today, has accused the company of destroying the original product, changing "milk chocolate" and "peanut butter" to substances that mirror them. Whereas Milton Hershey sourced fresh milk and used minimal ingredients, modern Hershey products are anything but fresh or even what the label implies. Also, at least 111 substances of unknown safety have been added to foods, drinks and supplements sold in the United States without alerting the US Food and Drug Administration, a new investigation found. This is on top of the exposure that has recently been brought to American foods in general, from food coloring to preservatives - leading companies to change their ingredient lists with a promise of never again lying to consumers. What were companies that attempted to bring purity to a contaminated marketplace, largely resulting from overcrowded cities, has turned ironically into the very thing that they were formed to fight. Now under "trusted brands" the foods that poisons Americans a century ago have made a reemergence.*The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.
For decades, midlife has been framed as a time of decline for women — medically, culturally, and personally. Halle Berry is on a mission to change that. On this episode of The Dr. Hyman Show, she shares how her own menopause journey exposed how little real support exists for the 60 million women navigating this transition. That experience ultimately led her to create ReSpin, the community she couldn't find when she needed it. Watch the full conversation on YouTube or listen wherever you get your podcasts. We discuss: • Why menopause is often missed — and how to take back control of your energy, mood, and metabolism • What changes in your brain, bones, and muscle and how to protect them in midlife • How comprehensive testing gives you a personalized roadmap for this phase of life • Why fatigue, low libido, and brain fog aren't “just aging” — and what improves when you address the root cause Your second act can be your strongest. It's a chance to reclaim your strength, your energy, and your future on your own terms. This conversation was recorded live at the Eudēmonia Summit. View Show Notes From This Episode Get Free Weekly Health Tips from Dr. Hyman https://drhyman.com/pages/picks?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Sign Up for Dr. Hyman's Weekly Longevity Journal https://drhyman.com/pages/longevity?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Join the 10-Day Detox to Reset Your Health https://drhyman.com/pages/10-day-detoxJoin the Hyman Hive for Expert Support and Real Results https://drhyman.com/pages/hyman-hive This episode is brought to you by Seed, BIOptimizers, PerfectAmino, BON CHARGE, Made In Cookware and Maui Nui. Go to seed.com/hyman and use code 20HYMAN to get 20% off your first month. Head to bioptimizers.com/hyman and use promo code HYMAN at checkout to save 15%. Go to bodyhealth.com and use code HYMAN20 to get 20% off your first order. Upgrade your routine. Head to boncharge.com/hyman and use code HYMAN for 15% off. Head to madeincookware.com and use the code DRHYMAN for 10% off your order. Learn more about the health benefits of venison and how to get yours, head over to mauinuivenison.com/hyman. (0:00) Halle Berry's health journey and the overlooked issue of menopause (1:21) Introduction to the Eudaimonia Summit (3:27) Women's health problems: Causes and personal stories (7:12) Misdiagnosis, confusion, and the mission to educate (10:01) Women's Health Initiative study and FDA updates (12:48) Hormone therapy and perimenopause symptoms (17:22) Lifestyle's role in hormonal health and disease prevention (22:12) Alcohol, nicotine, and long-term health risks like Alzheimer's (25:26) Early hormone replacement therapy and personalized care (28:15) Sexual health discussions and Halle Berry's ReSpin initiative (32:22) Cultural change, low-tox living, and structural health in menopause (37:01) Menopause symptoms variability and addressing health disparities (39:52) The need for medical education reform and JoyLux's contribution (41:12) Psychedelics in mental health treatment (43:43) Closing remarks and listener engagement (44:00) Disclaimer about podcast content
On today's episode, Andy travels to Austin to visit with Ways2Well founder Brigham Buhler at his Longevity Lab lab to discuss the search for the genetics secrets to eliminating chronic disease and how some species seem to live forever. They dig into why how the field is practiced today often leave patients without real answers, and why Buhler believes a more preventative, patient-focused approach could change that. Change Agents is an IRONCLAD Original Chapters: (00:00) Intro (02:08) Redesigning the Clinic: Making Healthcare Fun (07:10) How Insurance & PBMs Broke the Medical System (14:42) Big Pharma's War on Compounding & Telemedicine (18:22) Why Your Doctor Is Trapped in a Broken System (21:18) Ways2Well Tour: 80s Nostalgia & UV Murals (30:52) The Opioid Crisis & Brigham's Origin Story (38:25) Fighting the FDA & The Illusion of Surgical Safety (43:47) What Are Peptides & Why Pharma Wants Them (48:22) ALLEN: The Ways2Well AI Health Assistant (52:14) Debunking Medical Myths: Testosterone & HRT (58:16) Wearables & The Future of Proactive Health (01:10:57) Inside the Lab: Stem Cells, Red Light, & Hyperbaric Oxygen (01:17:48) Next-Level Detox: Blood Filtration (IBU) & Ozone Saunas (01:20:25) Gene Editing & The Future of Human Evolution Sponsors: Firecracker Farm Use code IRONCLAD to get 15% off your first order at https://firecracker.farm/ GHOSTBED: Go to https://www.GhostBed.com/IRONCLAD and use code IRONCLAD for an extra 15% off sitewide. Subscribe on Apple Podcasts: https://podcasts.apple.com/us/podcast/change-agents-with-andy-stumpf/id1677415740 Subscribe on Spotify: https://open.spotify.com/show/3SKmtN55V2AGbzHDo34DHI?si=5aefbba9abc844ed Learn more about your ad choices. Visit megaphone.fm/adchoices
On this episode of Vitality Radio, Jared sits down with Roz Marchant, founder of Hair's A Million, to explore the surprising story behind a natural hair health breakthrough. After losing her hair during cancer treatment, Roz began researching nutrient-dense, toxin-free ingredients that could support healthy hair and scalp function. What started as a personal experiment eventually became a widely used hair serum developed with a focus on clean ingredients and topical nutrition. Jared also shares the science behind his Hair Revive formula, created to address common internal factors linked to hair thinning such as nutrient depletion, stress, and hormonal shifts. Together they discuss the inside-out approach to supporting hair health, how lifestyle and nutrient status may influence hair growth cycles, and why ingredient integrity matters in both supplements and personal care products. If you're interested in natural strategies that support stronger, fuller, healthier hair, this episode is packed with insights.Products:Hairs a Million ProductsRidgecrest Herbals Hair ReviveBuy Hairs a Million Nutrient Infused Hair Serum AND Ridgecrest Herbals Hair Revive and get $20 off (for 30 days from air date)Thyme Out (Vitality Radio POW! Product of the Week 25% off with PROMO CODE: POW30)Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
About the Guest(s): Dr. Chad Woolner is a chiropractic physician who brings a wealth of knowledge and experience in utilizing advanced technologies to enhance patient care and wellness, including the use of laser and light-based therapies. Dr. Woolner has established himself as a credible voice in chiropractic care and is widely recognized for his expertise in integrating innovative treatments. Dr. Andrew Wells is an accomplished expert in natural health solutions, with a strong focus on the synergy between technology and healthcare. He collaborates closely with Dr. Woolner in providing insights into effective health practices, including weight loss strategies through cutting-edge light-based therapies. Episode Summary: In this engaging episode of the Laser Light Show, Dr. Chad Woolner and Dr. Andrew Wells discuss ground-breaking developments in light-based therapies, specifically focusing on weight and fat loss. The conversation revolves around Erchonia's latest technological advancements that promise to transform traditional approaches towards managing obesity and promoting healthier lifestyles. They introduce the new Zerona Z8 laser—an FDA-cleared, high-intensity violet laser designed to increase cellular energy and stimulate weight loss, offering new hope and tools for both individuals and practitioners. The episode delves into the rising challenges and perceptions surrounding obesity, weight loss interventions, and the growing popularity of GLP-1 medications. It highlights the importance of integrating tools like Zerona lasers with holistic lifestyle changes for a sustainable weight loss solution. Dr. Woolner and Dr. Wells stress the critical role of cellular energy in weight management and how addressing mitochondrial dysfunction can mitigate the obesity epidemic facing many. They advocate for an energy-first approach that prioritizes physiological health to facilitate consistent long-term behavioral shifts in diet and exercise regimens, ultimately fostering a more balanced and sustainable lifestyle. Key Takeaways: Light-based therapies, like the new Zerona Z8 laser, can revolutionize weight loss treatments by enhancing cellular energy and supporting long-term lifestyle changes. Chronic health issues and weight management difficulties often stem from insufficient cellular energy, making it essential to address mitochondrial dysfunction. The popular notion of light therapies as quick-fixes for melting fat fails to capture the full potential of these technologies as catalysts for broader health improvements. Incorporating tools like lasers with lifestyle adjustments, such as breath work and optimizing circadian rhythms, provides a comprehensive approach to weight loss. A successful weight loss strategy intertwines modern technological interventions with patient dedication to lifestyle changes, offering both immediate and enduring health benefits. Notable Quotes: "The paradigm shift with light-based therapies isn't just about melting away fat, but how they can act as a catalyst for sustainable energy and behavior change." - Dr. Chad Woolner "Patients often lack the physiological energy needed to make lasting lifestyle changes, and that's where therapies like the Zerona laser play a crucial role." - Dr. Andrew Wells "It's about solving mitochondrial dysfunction to empower and enable individuals to make healthier choices consistently." - Dr. Chad Woolner "When you increase your body's capacity to produce more energy, it not only supports weight loss but overall wellness and quality of life." - Dr. Andrew Wells "Using the Zerona laser as a catalyst can completely change someone's energy and mindset, paving the way for long-term health benefits." - Dr. Chad Woolner Resources: Erchonia's Zerona Lasers Book: Brain Energy by Dr. Chris Palmer Dr. Andrew Huberman podcast on circadian rhythm Enhance your understanding of cutting-edge weight loss technologies by listening in on this enlightening episode. Stay tuned for more insights from Dr. Chad Woolner and Dr. Andrew Wells on the Laser Light Show, revealing how innovative therapies and holistic approaches can transform health practices.
© 2020-2026 Ivy Podcast Discovery LLC
